AptarGroup (ATR) 10-Q 5 Nov 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Oct. 30, 2018
Document and Entity Information
Entity Registrant Name	APTARGROUP INC
Entity Central Index Key	896,622
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		62,814,068
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Net sales	$ 665,775	$ 624,326	$ 2,079,733	$ 1,843,388
Operating Expenses:
Cost of sales (exclusive of depreciation and amortization shown below)	435,379	407,781	1,355,445	1,192,129
Selling, research & development and administrative	103,574	95,536	323,146	292,274
Depreciation and amortization	41,857	40,087	123,133	114,660
Restructuring initiatives	23,852		48,002
Total Operating Expenses	604,662	543,404	1,849,726	1,599,063
Operating Income	61,113	80,922	230,007	244,325
Other (Expense) Income:
Interest expense	(8,735)	(9,733)	(24,754)	(25,707)
Interest income	1,537	1,113	6,306	2,086
Equity in results of affiliates	(45)	(72)	(130)	(142)
Miscellaneous, net	(2,928)	(2,712)	(4,372)	(1,996)
Total Other Income (Expense)	(10,171)	(11,404)	(22,950)	(25,759)
Income before Income Taxes	50,942	69,518	207,057	218,566
Provision for Income Taxes	11,920	15,989	52,966	48,043
Net Income	39,022	53,529	154,091	170,523
Net (Income) Loss Attributable to Noncontrolling Interests	(26)	(6)	(20)	(6)
Net Income Attributable to AptarGroup, Inc.	$ 38,996	$ 53,523	$ 154,071	$ 170,517
Net Income Attributable to AptarGroup, Inc. Per Common Share:
Basic (in dollars per share)	$ 0.63	$ 0.86	$ 2.47	$ 2.73
Diluted (in dollars per share)	$ 0.60	$ 0.83	$ 2.38	$ 2.64
Average number of shares outstanding:
Basic (in shares)	62,378	62,592	62,304	62,527
Diluted (in shares)	65,129	64,821	64,822	64,626
Dividends per Common Share (in dollars per share)	$ 0.34	$ 0.32	$ 0.98	$ 0.96

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net Income	$ 39,022	$ 53,529	$ 154,091	$ 170,523
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(9,869)	17,903	(53,157)	69,505
Changes in treasury locks, net of tax	3	7	17	21
(Gain) loss on derivatives, net of tax	(1,166)	(3,591)	1,046	(3,591)
Defined benefit pension plan, net of tax
Amortization of prior service cost included in net income, net of tax	90	74	278	210
Amortization of net loss included in net income, net of tax	1,243	850	3,754	2,489
Total defined benefit pension plan, net of tax	1,333	924	4,032	2,699
Total other comprehensive income (loss)	(9,699)	15,243	(48,062)	68,634
Comprehensive Income (Loss)	29,323	68,772	106,029	239,157
Comprehensive (Income) Loss Attributable to Noncontrolling Interests	(15)	(11)	(4)	(18)
Comprehensive Income Attributable to AptarGroup, Inc.	$ 29,308	$ 68,761	$ 106,025	$ 239,139

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current Assets:
Cash and equivalents	$ 291,382	$ 712,640
Accounts and notes receivable, less allowance for doubtful accounts of $2,702 in 2018 and $3,161 in 2017	580,450	510,426
Inventories	394,264	337,216
Prepaid and other	118,613	109,791
Total Current Assets	1,384,709	1,670,073
Property, Plant and Equipment:
Buildings and improvements	446,216	416,241
Machinery and equipment	2,352,421	2,237,655
Property, Plant and Equipment, Gross	2,798,637	2,653,896
Less: Accumulated depreciation	(1,842,885)	(1,811,819)
Property, Plant and Equipment, Net	955,752	842,077
Land	25,355	25,829
Total Property, Plant and Equipment	981,107	867,906
Other Assets:
Investments in affiliates	19,143	9,444
Goodwill	699,330	443,887
Intangible assets	283,110	95,460
Miscellaneous	39,597	51,053
Total Other Assets	1,041,180	599,844
Total Assets	3,406,996	3,137,823
Current Liabilities:
Notes payable, including revolving credit facilities	153,236	4,336
Current maturities of long-term obligations, net of unamortized debt issuance costs	64,039	61,833
Accounts payable and accrued liabilities	524,528	461,579
Total Current Liabilities	741,803	527,748
Long-term obligations, net of unamortized debt issuance costs	1,131,737	1,191,146
Deferred Liabilities and Other:
Deferred income taxes	48,857	20,995
Retirement and deferred compensation plans	67,704	80,278
Deferred and other non-current liabilities	24,837	5,608
Commitments and contingencies
Total Deferred Liabilities and Other	141,398	106,881
AptarGroup, Inc. stockholders' equity
Common stock, $.01 par value, 199 million shares authorized, 67.2 and 66.7 million shares issued as of September 30, 2018 and December 31, 2017, respectively	672	667
Capital in excess of par value	670,710	609,471
Retained earnings	1,345,851	1,301,147
Accumulated other comprehensive (loss)	(301,348)	(253,302)
Less treasury stock at cost, 4.5 and 4.9 million shares as of September 30, 2018 and December 31, 2017, respectively	(324,141)	(346,245)
Total AptarGroup, Inc. Stockholders' Equity	1,391,744	1,311,738
Noncontrolling interests in subsidiaries	314	310
Total Stockholders' Equity	1,392,058	1,312,048
Total Liabilities and Stockholders' Equity	$ 3,406,996	$ 3,137,823

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands, shares in Millions	Sep. 30, 2018	Dec. 31, 2017
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts and notes receivable, allowance for doubtful accounts (in dollars)	$ 2,702	$ 3,161
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	199	199
Common stock, shares issued	67.2	66.7
Treasury stock, shares	4.5	4.9

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)	Common Stock Par Value	Treasury Stock	Capital in Excess of Par Value	Non-Controlling Interest	Total
Balance at Dec. 31, 2016	$ 1,197,234	$ (319,709)	$ 660	$ (250,917)	$ 546,682	$ 292	$ 1,174,242
Increase (Decrease) in Stockholders' Equity
Net Income	170,517					6	170,523
Foreign currency translation adjustments		69,493				12	69,505
Changes in unrecognized pension gains/losses and related amortization, net of tax		2,699					2,699
Changes in treasury locks, net of tax		21					21
Changes in derivative gains/losses, net of tax		(3,591)					(3,591)
Stock awards and option exercises			11	23,938	57,742		81,691
Cash dividends declared on common stock	(60,002)						(60,002)
Treasury stock purchased				(72,270)			(72,270)
Common stock repurchased and retired	(36,173)		(5)		(4,816)		(40,994)
Balance at Sep. 30, 2017	1,271,576	(251,087)	666	(299,249)	599,608	310	1,321,824
Balance at Jun. 30, 2017	1,238,123	(266,325)	665	(257,731)	594,145	299	1,309,176
Increase (Decrease) in Stockholders' Equity
Net Income	53,523					6	53,529
Foreign currency translation adjustments		17,898				5	17,903
Changes in unrecognized pension gains/losses and related amortization, net of tax		924					924
Changes in treasury locks, net of tax		7					7
Changes in derivative gains/losses, net of tax		(3,591)					(3,591)
Stock awards and option exercises			1	4,024	5,463		9,488
Cash dividends declared on common stock	(20,070)						(20,070)
Treasury stock purchased				(45,542)			(45,542)
Balance at Sep. 30, 2017	1,271,576	(251,087)	666	(299,249)	599,608	310	1,321,824
Balance at Dec. 31, 2017	1,301,147	(253,302)	667	(346,245)	609,471	310	1,312,048
Increase (Decrease) in Stockholders' Equity
Net Income	154,071					20	154,091
Adoption of accounting standards	2,937						2,937
Foreign currency translation adjustments		(53,141)				(16)	(53,157)
Changes in unrecognized pension gains/losses and related amortization, net of tax		4,032					4,032
Changes in treasury locks, net of tax		17					17
Changes in derivative gains/losses, net of tax		1,046					1,046
Stock awards and option exercises			11	26,009	67,705		93,725
Cash dividends declared on common stock	(60,989)						(60,989)
Treasury stock purchased				(3,905)			(3,905)
Common stock repurchased and retired	(51,315)		(6)		(6,466)		(57,787)
Balance at Sep. 30, 2018	1,345,851	(301,348)	672	(324,141)	670,710	314	1,392,058
Balance at Jun. 30, 2018	1,328,034	(291,660)	668	(336,278)	646,449	299	1,347,512
Increase (Decrease) in Stockholders' Equity
Net Income	38,996					26	39,022
Foreign currency translation adjustments		(9,858)				(11)	(9,869)
Changes in unrecognized pension gains/losses and related amortization, net of tax		1,333					1,333
Changes in treasury locks, net of tax		3					3
Changes in derivative gains/losses, net of tax		(1,166)					(1,166)
Stock awards and option exercises			4	12,137	24,261		36,402
Cash dividends declared on common stock	(21,179)						(21,179)
Balance at Sep. 30, 2018	$ 1,345,851	$ (301,348)	$ 672	$ (324,141)	$ 670,710	$ 314	$ 1,392,058

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Flows from Operating Activities:
Net income	$ 154,091	$ 170,523
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	113,555	107,017
Amortization	9,578	7,643
Stock based compensation	14,829	15,005
Provision for (recovery of) doubtful accounts	190	124
Gain on disposition of fixed assets	(979)	67
Deferred income taxes	(5,414)	(2,265)
Defined benefit plan expense	14,466	12,932
Equity in results of affiliates	130	142
Changes in balance sheet items, excluding effects from acquisitions and foreign currency adjustments:
Accounts and other receivables	(72,620)	(46,038)
Inventories	(41,183)	(1,392)
Prepaid and other current assets	(807)	(10,839)
Accounts payable and accrued liabilities	55,921	49,158
Income taxes payable	(7,481)	2,061
Retirement and deferred compensation plan liabilities	(21,534)	(20,621)
Other changes, net	(3,157)	(18,355)
Net Cash Provided by Operations	209,585	265,162
Cash Flows from Investing Activities:
Capital expenditures	(145,321)	(120,803)
Proceeds from sale of property and equipment	4,056	2,345
Insurance proceeds	10,631
Settlement for derivative		(66,155)
Acquisition of business, net of cash acquired	(527,916)
Acquisition of intangible assets	(346)
Investment in unconsolidated affiliate	(10,000)	(5,000)
Notes receivable, net	216	451
Net Cash Used by Investing Activities	(668,680)	(189,162)
Cash Flows from Financing Activities:
Proceeds from notes payable	18,003
Repayments of notes payable	(6,395)
Proceeds and repayments of short term credit facility, net	139,384	(63,905)
Proceeds from long-term obligations	10,092	625,525
Repayments of long-term obligations	(67,026)	(4,836)
Dividends paid	(60,989)	(60,002)
Credit facility costs		(2,937)
Proceeds from stock option exercises	78,896	66,686
Purchase of treasury stock	(3,905)	(72,270)
Common stock repurchased and retired	(57,787)	(40,994)
Net Cash Provided (Used) by Financing Activities	50,273	447,267
Effect of Exchange Rate Changes on Cash	(7,436)	29,112
Net Increase (Decrease) in Cash and Equivalents and Restricted Cash	(416,258)	552,379
Cash and Equivalents and Restricted Cash at Beginning of Period	712,640	466,287
Cash and Equivalents and Restricted Cash at End of Period	$ 296,382	$ 1,018,666

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2016
Restricted cash included in the line item prepaid and other on the Condensed Consolidated Balance Sheets as shown below represents amounts held in escrow related to the CSP Technologies acquisition.
Cash and equivalents	$ 291,382	$ 712,640	$ 1,018,666
Restricted cash included in prepaid and other	5,000
Total Cash and Equivalents and Restricted Cash shown in the Statement of Cash Flows	$ 296,382	$ 712,640	$ 1,018,666	$ 466,287

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2018
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of AptarGroup, Inc. and our subsidiaries. The terms “AptarGroup”, “Aptar” or “Company” as used herein refer to AptarGroup, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated. Certain previously reported amounts have been reclassified to conform to the current period presentation. In the opinion of management, the unaudited Condensed Consolidated Financial Statements (the “Condensed Consolidated Financial Statements”) include all normal recurring adjustments necessary for a fair statement of consolidated financial position, results of operations, comprehensive income, changes in equity and cash flows for the interim periods presented. The accompanying Condensed Consolidated Financial Statements have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information presented not misleading. Also, certain financial position data included herein was derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 but does not include all disclosures required by U.S. GAAP. Accordingly, these Condensed Consolidated Financial Statements and related notes should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. The results of operations of any interim period are not necessarily indicative of the results that may be expected for the year. During the quarter ended June 30, 2018, primarily based on published estimates, which indicate that Argentina's three-year cumulative inflation rate has exceeded 100%, we concluded that Argentina has become a highly inflationary economy. Beginning July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiaries. We have changed the functional currency from the Argentinian peso to the U.S. dollar. Local currency monetary assets and liabilities have been remeasured into U.S. dollars using exchange rates as of the latest balance sheet date, with remeasurement adjustments and other transaction gains and losses recognized in net earnings. During the third quarter of 2018, we recognized approximately $1.0 million of additional losses due to these changes. Our Argentinian operations contributed approximately 2.0% of consolidated net assets and revenues at and for the nine months ended September 30, 2018. ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification. In May 2014, the FASB issued ASU 2014-09, which amended the guidance for recognition of revenue from customer contracts. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018, we adopted this standard and all the related amendments (the “new revenue standard”) for all contracts. This adoption was accounted for using the modified retrospective method. We recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the January 1, 2018 opening balance of retained earnings. Comparative information for the prior periods has not been restated and continues to be reported under the accounting standards in effect prior to January 1, 2018. Balance at Balance at December 31, 2017 Adjustment January 1, 2018 Consolidated Balance Sheets Assets Inventories $ 337,216 $ (14,637) $ 322,579 Prepaid and other 109,791 13,984 123,775 Liabilities Accounts payable and accrued liabilities 461,579 (5,706) 455,873 Deferred income taxes 20,995 1,292 22,287 Deferred and other non-current liabilities 5,608 824 6,432 Stockholders’ Equity Retained earnings 1,301,147 2,937 1,304,084 A majority of our sales revenue continues to be recognized when products are shipped from our manufacturing facilities. For certain custom product and tooling sales where revenue was previously recognized when the products were shipped, we now recognize revenue over the time required to manufacture the product or build the tool in accordance with the new revenue standard. We also have certain extended warranty contracts, which under the new standard are considered a separate performance obligation and are required to be deferred and recognized into revenue over the life of the agreement. In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated statements of income and balance sheets is as follows: For the Three Months Ended September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 341,760 $ 340,787 $ 973 Pharma 227,515 227,526 (11) Food + Beverage 96,500 96,478 22 Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 435,379 434,601 778 Provision for income taxes 11,920 11,866 54 Net income 39,022 38,870 152 For the Nine Months Ended September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 1,088,469 $ 1,087,922 $ 547 Pharma 698,851 699,299 (448) Food + Beverage 292,413 292,437 (24) Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 1,355,445 1,354,844 601 Provision for income taxes 52,966 53,138 (172) Net income 154,091 154,445 (354) September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Balance Sheets Assets Inventories $ 394,264 $ 409,502 $ (15,238) Prepaid and other 118,613 102,767 15,846 Liabilities Accounts payable and accrued liabilities 524,528 528,081 (3,553) Deferred income taxes 48,857 47,737 1,120 Deferred and other non-current liabilities 24,837 24,379 458 Stockholders’ Equity Retained earnings 1,345,851 1,343,268 2,583 In January 2016, the FASB issued ASU 2016-01, which provides guidance on the classification and measurement of financial assets and liabilities (equity securities and financial liabilities) under the fair value option and the presentation and disclosure requirements for financial instruments. In February 2018, ASU 2018-03 was issued to clarify certain aspects of the guidance issued in January 2016. The guidance modifies how entities measure equity investments and present changes in the fair value of financial liabilities. Under the new guidance, entities measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any related changes in fair value in net income unless the investments qualify for the new practicality exception. A measurement alternative exists for those equity investments that do not have a readily determinable fair value. These investments may be measured at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The standard also includes a new impairment model for equity investments without readily determinable fair values. The new model is a single-step model under which the Company is required to perform a qualitative assessment each reporting period to identify impairment. When a qualitative assessment indicates that an impairment exists, the Company will estimate the fair value of the investment and recognize in current earnings an impairment loss equal to the difference between the fair value and the carrying amount of the equity investment. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018. In February 2016, the FASB issued ASU 2016-02 and subsequent amendments, which requires organizations to recognize leases on the balance sheet, and disclose key information about leasing arrangements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and recognition of expense in the income statement. The new standard is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. We expect to adopt the new standard on its effective date. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. We expect to adopt the new standard on January 1, 2019 and use the effective date (option 1) as our date of initial application. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. The new standard also provides practical expedients for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. While we continue to assess all of the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our operating leases and the significant new disclosures about our leasing activities. In August 2016, the FASB issued ASU 2016-15, which provides guidance on the classification of certain cash receipts and cash payments within the statement of cash flows. This guidance provides clarification for the following types of transactions: debt prepayment or extinguishment costs, settlement of zero-coupon debt instruments or other debt instruments with coupon rates that are insignificant in relation to the effective interest rate of the borrowing, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, proceeds from the settlement of corporate-owned life insurance, distributions received from equity method investees and beneficial interest in securitization transactions. The guidance also clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. However, early adoption was permitted and an entity that elects early adoption must adopt all of the amendments on a retrospective basis in the period of adoption. The Company adopted this standard in the fourth quarter of 2017. In November 2016, the FASB issued ASU 2016-18, which provides guidance to address the diversity in the classification and presentation of changes in restricted cash on the statement of cash flows. The amendments in this standard require that a statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018 and appropriate disclosures are included on the statement of cash flows to the extent applicable. In January 2017, the FASB issued ASU 2017-01, which provides guidance to clarify the definition of a business to assist entities in evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments in this standard provide a screen to determine when an integrated set of assets and activities (collectively referred to as a “set”) is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. If the screen is not met, the amendments in this update (1) require that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) remove the evaluation of whether a market participant could replace missing elements. The amendments also narrow the definition of the term “output” so that the term is consistent with how outputs are described in the new guidance for revenue recognition. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018. In March 2017, the FASB issued ASU 2017-07, which provides guidance to disaggregate the current service cost component from the other components of net periodic benefit costs. The service cost component should be presented within compensation costs while the other components should be presented outside of income from operations. The guidance also clarifies that only the service cost component is eligible for capitalization. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018 and the prior periods were restated as follows: Original Revised Balance Adjustment Balance Revised Condensed Consolidated Statements of Income Three Months Ended September 30, 2017 Cost of sales (exclusive of depreciation and amortization) $ 408,081 $ (300) $ 407,781 Selling, research & development and administrative 95,748 (212) 95,536 Total Operating Expenses 543,916 (512) 543,404 Operating Income 80,410 512 80,922 Miscellaneous, net (2,200) (512) (2,712) Total Other (Expense) Income (10,892) (512) (11,404) Income before Income Taxes 69,518 — 69,518 Nine Months Ended September 30, 2017 Cost of sales (exclusive of depreciation and amortization) $ 1,192,967 $ (838) $ 1,192,129 Selling, research & development and administrative 292,923 (649) 292,274 Total Operating Expenses 1,600,550 (1,487) 1,599,063 Operating Income 242,838 1,487 244,325 Miscellaneous, net (509) (1,487) (1,996) Total Other (Expense) Income (24,272) (1,487) (25,759) Income before Income Taxes 218,566 — 218,566 In May 2017, the FASB issued ASU 2017-09, which provides clarification on applying the standards for stock compensation accounting. The new standard provides guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018. In August 2017, the FASB issued ASU 2017-12, which provides new guidance to improve the accounting for hedging activities. The guidance changes the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition, the guidance makes certain targeted improvements to simplify the application of the hedge accounting guidance in current U.S. GAAP. The new standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. However, early application is permitted in any interim period after the issuance of this guidance. The Company adopted this standard in the third quarter of 2017. See details in Note 9 – Derivative Instruments and Hedging Activities. Other accounting standards that have been issued by the FASB or other standards-setting bodies did not have a material impact on our Condensed Consolidated Financial Statements. RETIREMENT OF COMMON STOCK During the first nine months of 2018, the Company repurchased 668 thousand shares of common stock, of which 623 thousand shares were immediately retired. During the first nine months of 2017, the Company repurchased 1.4 million shares of common stock, of which 512 thousand shares were immediately retired. Common stock was reduced by the number of shares retired at $0.01 par value per share. The Company allocates the excess purchase price over par value between additional paid-in capital and retained earnings. INCOME TAXES The Company computes taxes on income in accordance with the tax rules and regulations of the many taxing authorities where income is earned. The income tax rates imposed by these taxing authorities may vary substantially. Taxable income may differ from pre-tax income for financial accounting purposes. To the extent that these differences create temporary differences between the tax basis of an asset or liability and our reported amount in the financial statements, an appropriate provision for deferred income taxes is made. The Tax Cuts and Jobs Act (the “TCJA”) was enacted in the United States on December 22, 2017. The TCJA lowered the corporate tax rate from 35.0% to 21.0% and imposed a one-time transition tax on unremitted earnings as of the end of 2017, and featured many other tax law provisions. New provisions for 2018 include, most notably, a tax on global intangible low-taxed income (“GILTI”) and the base erosion anti-abuse tax (“BEAT”), repeal of the domestic manufacturing deduction and limitations on the deductibility of executive compensation. The SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the U.S. GAAP application of the TCJA. SAB 118 provides us up to a year to finalize accounting for the impacts of the TCJA. The Company estimated provisional tax amounts related to the transition tax and components of the revaluation of deferred tax assets and liabilities for the period ended December 31, 2017. This resulted in the recognition of a net tax charge of approximately $24.8 million, comprised of a provisional charge of $31.6 million for the transition tax and a provisional benefit of $6.8 million related to the corporate rate change. While our accounting for the enactment of the new U.S. tax legislation is not complete, during the three months ended September 30, 2018, we recognized a provisional, discrete $1.9 million net tax benefit, consisting of a provisional $2.8 million benefit related to the change in the corporate tax rate that was partially offset by a provisional $0.9 million charge for the transition tax liability. During the nine months ended September 30, 2018, we recognized $5.4 million in provisional, discrete net tax benefits, composed of the $2.8 million benefit for the change in corporate tax rate and a net $2.6 million decrease to our transition tax liability. The benefit for the lower transition tax liability reflects additional guidance issued by the U.S. Treasury during 2018. The Company expects both provisional amounts to be finalized in the fourth quarter of 2018 when the 2017 U.S. tax return filings are completed. The Company has elected to account for the tax on GILTI as a period cost and not as a measure of deferred taxes in the current period. All of the Company’s non-U.S. earnings are subject to U.S. taxation, either from the TCJA transition tax on accumulated non-U.S. earnings as of the end of 2017 or the GILTI provisions on non-U.S. earnings going forward. The Company maintains its assertion that the cash and distributable reserves at its non-U.S. affiliates are indefinitely reinvested. The Company will provide for the necessary withholding and local income taxes when management decides that an affiliate should make a distribution. These decisions are made taking into consideration the financial requirements of the non-U.S. affiliates and the global cash management goals of the Company. The Company provides a liability for the amount of unrecognized tax benefits from uncertain tax positions. This liability is provided whenever the Company determines that a tax benefit will not meet a more-likely-than-not threshold for recognition. See Note 5 - Income Taxes for more information.

REVENUE

REVENUE	9 Months Ended
	Sep. 30, 2018
REVENUE.
REVENUE	NOTE 2 – REVENUE At contract inception, Aptar assesses the goods and services promised in its contracts with customers and identifies a performance obligation for each promise to transfer a good or service (or bundle of goods or services) that is distinct. To identify the performance obligations, the Company considers all the goods or services promised in the contract, whether explicitly stated or implied based on customary business practices. For a contract that has more than one performance obligation, the Company allocates the total contract consideration to each distinct performance obligation on a relative standalone selling price basis. Revenue is recognized when (or as) the performance obligations are satisfied (i.e., when the customer obtains control of the good or service). The majority of the Company’s revenues are derived from product and tooling sales; however Aptar also receives revenues from service, license, exclusivity and royalty arrangements, which are considered insignificant. Revenue by segment and geography for the three and nine months ended September 30, 2018 is as follows: For the Three Months Ended September 30, 2018 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 190,267 $ 83,353 $ 44,653 $ 23,487 $ 341,760 Pharma 161,733 50,126 6,165 9,491 227,515 Food + Beverage 29,472 47,870 7,476 11,682 96,500 Total $ 381,472 $ 181,349 $ 58,294 $ 44,660 $ 665,775 For the Nine Months Ended September 30, 2018 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 622,184 $ 252,709 $ 140,238 $ 73,338 $ 1,088,469 Pharma 520,574 132,496 19,229 26,552 698,851 Food + Beverage 90,185 143,005 23,343 35,880 292,413 Total $ 1,232,943 $ 528,210 $ 182,810 $ 135,770 $ 2,079,733 Aptar performs its obligations under a contract with a customer by transferring goods and/or services in exchange for consideration from the customer. The timing of performance will sometimes differ from the timing of the receipt of the associated consideration from the customer, thus resulting in the recognition of a contract asset or a contract liability. Aptar recognizes a contract asset when it transfers control of goods or services to a customer prior to invoicing for the related performance obligation. The contract asset is transferred to accounts receivable when the product is shipped and invoiced to the customer. Aptar recognizes a contract liability if the customer's payment of consideration precedes the entity's performance. The opening and closing balances of Aptar’s contract asset and contract liabilities are as follows: Balance as of Balance as of January 1, 2018 September 30, 2018 Increase/ (opening) (closing) (Decrease) Contract asset (current) $ 13,984 $ 15,846 $ 1,862 Contract asset (long-term) $ — $ — $ — Contract liability (current) $ 15 $ 413 $ 398 Contract liability (long-term) $ 824 $ 458 $ (366) The differences in the opening and closing balances of the Company’s contract asset and contract liabilities are primarily the result of timing differences between the Company’s performance and the customer’s payment. The amount of revenue recognized in the current year that was included in the opening contract liability balance was $154 thousand. Determining the Transaction Price In most cases, the transaction price for each performance obligation is stated in the contract. In determining the variable amounts of consideration within the transaction price (such as volume-based customer rebates), Aptar includes an estimate of the expected amount of consideration as revenue. Aptar applies the expected value method based on all of the information (historical, current, and forecast) that is reasonably available and identifies reasonable estimates based on this information. The Company applies the method consistently throughout the contract when estimating the effect of an uncertainty on the amount of variable consideration to which it will be entitled. Point in Time Performance Obligations For product and tooling sales considered to be point in time, Aptar typically assesses, among other things, the shipping terms of the contract, shipping being one of the indicators of transfer of control. For free on board (“FOB”) shipping point terms, revenue is recognized at the time of shipment. The performance obligation with respect to the sale of goods is satisfied at the time of shipment because the customer gains control at that time. Once the goods are shipped, the Company is precluded from redirecting the shipment to another customer. With respect to FOB destination sales, shipping and/or handling costs that occur before the customer obtains control of the goods are deemed to be fulfilment activities and are accounted for as fulfilment costs and revenue is recorded upon final delivery to the customer location. Over Time Performance Obligations For performance obligations related to manufacturing of highly customized products that have no alternative use to the Company and for which the Company has an enforceable right to payment for performance completed to date, the Company transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the Output Method based on the number of products produced. For similar performance obligations related to our tooling sales, the Company transfers control and recognizes revenue over time by measuring progress towards complete satisfaction using the Input Method based on costs incurred relative to total estimated costs to completion. We believe these measurements provide a faithful depiction of the transfer of goods as the costs incurred reflect the value of the products produced. Product Sales Aptar primarily manufactures dispensing systems for our Beauty + Home, Pharma, and Food + Beverage customers. The amount of consideration is typically fixed for such customers. At the time of delivery, the customer is invoiced the agreed-upon price. Revenue from product sales is typically recognized upon manufacture or shipment, when control of the goods transfers to the customer. To determine when the control transfers, Aptar typically assesses, among other things, the shipping terms of the contract, shipping being one of the indicators of transfer of control. A majority of product sales are sold FOB shipping point. For FOB shipping point shipments, control of the goods transfers to the customer at the time of shipment of the goods. Therefore, Aptar's performance obligation is satisfied at the time of shipment. Aptar has elected to account for shipping and handling costs that occur after the customer has obtained control of a good as fulfillment costs rather than as a promised service. Aptar does not have any material significant payment terms as payment is typically received shortly after the point of sale. There also exist instances where Aptar manufactures highly customized products that have no alternative use to Aptar and for which Aptar has an enforceable right to payment for performance completed to date. For these products, the Company transfers control and recognizes revenue over time by measuring progress towards completion using the Output Method based on the number of products produced. As we normally make our products to a customer’s order, the time between production and shipment of our products is typically within a few weeks. As a part of its customary business practice, Aptar offers a standard warranty that the products will materially comply with the technical specifications and will be free from material defects. Because such warranties are not sold separately, do not provide for any service beyond a guarantee of a product’s initial specifications, and are not required by law, there is no revenue deferral for these types of warranties. Tooling Sales Aptar also builds or contracts for molds and other tools (collectively defined as “tooling”) necessary to produce our products. As with product sales, Aptar recognizes revenue when control of the tool transfers to the customer. If the tooling is highly customized with no alternative use to Aptar and Aptar has an enforceable right to payment for performance completed to date, the Company transfers control and recognizes revenue over time by measuring progress towards completion using the Input Method based on costs incurred relative to total estimated costs to completion. Otherwise, revenue for the tooling is recognized at the point in time when the customer approves the tool. Aptar does not have any material significant payment terms as payment is typically either received during the mold-build process or shortly after completion. In certain instances, Aptar offers extended warranties on our tools above and beyond the normal standard warranties. Aptar normally receives payment at the inception of the contract and recognizes revenue over the term of the contract. At January 1, 2018, $839 thousand of unearned revenue associated with outstanding contracts was reported in Accounts Payable and Other Liabilities. At September 30, 2018, the unearned amount was $871 thousand. Aptar expects to recognize approximately $10 2 thousand of the unearned amount during the remainder of 2018, $367 thousand in 2019, and $402 thousand thereafter. Contract Costs Aptar does not incur material costs to obtain or fulfill revenue contracts. Practical Expedients Significant financing component: Aptar elected not to adjust the promised consideration for the time value of money for contracts where the difference between the time of payment and performance is one year or less. Remaining performance obligations: Aptar elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. In addition, the Company has elected not to disclose the expected consideration related to performance obligations where the Company recognizes revenue in the amount it has a right to invoice (e.g., usage-based pricing terms).

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2018
INVENTORIES
INVENTORIES	NOTE 3 - INVENTORIES Inventories, by component, consisted of: September 30, December 31, Raw materials $ 111,985 $ 99,196 Work in process 127,569 107,307 Finished goods 154,710 130,713 Total $ 394,264 $ 337,216

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2018
GOODWILL AND OTHER INTANGIBLE ASSETS
GOODWILL AND OTHER INTANGIBLE ASSETS	NOTE 4 – GOODWILL AND OTHER INTANGIBLE ASSETS The changes in the carrying amount of goodwill by reporting segment since December 31, 2017 are as follows: Beauty + Food + Corporate Home Pharma Beverage & Other Total Goodwill $ 223,947 $ 203,069 $ 16,871 $ 1,615 $ 445,502 Accumulated impairment losses — — — (1,615) (1,615) Balance as of December 31, 2017 $ 223,947 $ 203,069 $ 16,871 $ — $ 443,887 Acquisition 5,565 154,827 106,389 — 266,781 Foreign currency exchange effects (4,853) (6,237) (248) — (11,338) Goodwill $ 224,659 $ 351,659 $ 123,012 $ 1,615 $ 700,945 Accumulated impairment losses — — — (1,615) (1,615) Balance as of September 30, 2018 $ 224,659 $ 351,659 $ 123,012 $ — $ 699,330 The table below shows a summary of intangible assets as of September 30, 2018 and December 31, 2017. September 30, 2018 December 31, 2017 Weighted Average Gross Gross Amortization Period Carrying Accumulated Net Carrying Accumulated Net (Years) Amount Amortization Value Amount Amortization Value Amortized intangible assets: Patents 0.3 $ 7,645 $ (7,535) $ 110 $ 7,819 $ (7,806) $ 13 Acquired technology 13.5 93,171 (16,786) 76,385 47,571 (14,624) 32,947 Customer relationships 14.6 199,591 (18,162) 181,429 68,886 (13,401) 55,485 Trademarks and trade names 7.0 21,333 (5,311) 16,022 6,965 (4,485) 2,480 License agreements and other 9.3 19,808 (10,644) 9,164 14,862 (10,327) 4,535 Total intangible assets 13.2 $ 341,548 $ (58,438) $ 283,110 $ 146,103 $ (50,643) $ 95,460 Aggregate amortization expense for the intangible assets above for the quarters ended September 30, 2018 and 2017 was $4,005 and $2,708, respectively. Aggregate amortization expense for the intangible assets above for the nine months ended September 30, 2018 and 2017 was $9,578 and $7,643, respectively. Future estimated amortization expense for the years ending December 31 is as follows: 2018 $ 6,023 (remaining estimated amortization for 2018) 2019 23,888 2020 22,786 2021 22,407 2022 and thereafter 208,006 Future amortization expense may fluctuate depending on changes in foreign currency rates. The estimates for amortization expense noted above are based upon foreign exchange rates as of September 30, 2018.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2018
INCOME TAXES
INCOME TAXES	NOTE 5 – INCOME TAXES The TCJA was enacted in the U.S. on December 22, 2017. The TCJA lowered the corporate tax rate from 35.0% to 21.0% and imposed a one-time transition tax on unremitted earnings as of the end of 2017, among other changes. New provisions for 2018 include, most notably, a tax on GILTI and BEAT, repeal of the domestic manufacturing deduction and limitations on the deductibility of executive compensation. The SEC issued SAB 118 to address the U.S. GAAP application of the TCJA. SAB 118 provides us up to a year to finalize accounting for the impacts of the TCJA. The Company estimated provisional tax amounts related to the transition tax and components of the revaluation of deferred tax assets and liabilities for the period ended December 31, 2017. This resulted in the recognition of a net tax charge of approximately $24.8 million, comprised of a provisional charge of $31.6 million for the transition tax and a provisional benefit of $6.8 million related to the corporate rate change. While our accounting for the enactment of the new U.S. tax legislation is not complete, during the three months ended September 30, 2018, we recognized a provisional, discrete $1.9 million net tax benefit, consisting of a provisional $2.8 million benefit related to the change in the corporate tax rate that was partially offset by a provisional $0.9 million charge for the transition tax liability. During the nine months ended September 30, 2018, we recognized $5.4 million in provisional, discrete net tax benefits, comprised of the $2.8 million benefit for the change in corporate tax rate and a net $2.6 million decrease to our transition tax liability. The benefit for the lower transition tax liability reflects additional guidance issued by the U.S. Treasury during 2018. The Company expects both provisional amounts to be finalized in the fourth quarter of 2018 when the 2017 U.S. tax return filings are completed. The Company has elected to account for the tax on GILTI as a period cost and not as a measure of deferred taxes in the current period. The reported effective tax rate for the three months ended September 30, 2018 was 23.4%. The current year rate was favorably impacted by $4.5 million of tax benefits from employee share-based compensation along with a $1.9 million benefit from the TCJA provisional items (see above) and $3.5 million of refunds from the settlement of tax claims. These favorable items were partially offset in the quarter by a $1.4 million impact of foreign valuation allowances, $1.5 million from the new U.S. tax provisions, including GILTI and BEAT and $4.0 million of other discrete and non-discrete tax items. The reported effective tax rate for the three months ended September 30, 2017 was 23.0%. The prior year tax rate was favorably impacted by a $4.4 million benefit of refunds from the settlement of tax claims. The reported effective tax rate for the nine months ended September 30, 2018 was 25.6%. The tax rate was favorably impacted by $9.9 million of tax benefits from employee share-based compensation along with a $5.4 million benefit from the TCJA provisional items (see above) and $3.9 million of refunds from the settlement of tax claims. These favorable items were partially offset by a $6.3 million impact from the new U.S. tax provisions, including GILTI and BEAT and $4.5 million of other discrete and non-discrete tax items. The reported effective tax rate for the nine months ended September 30, 2017 was 22.0%. The prior year tax rate was favorably impacted by $8.8 million of tax benefits from employee share-based compensation, a $3.4 million net benefit from the settlement of tax claims and a $3.6 million benefit from repatriation activities to the U.S. The Company had approximately $3.5 million and $3.1 million recorded for income tax uncertainties as of September 30, 2018 and December 31, 2017, respectively. The uncertain amounts, if recognized, that would impact the effective tax rate are $3.5 million and $3.1 million, respectively. The Company estimates that it is reasonably possible that the liability for uncertain tax positions will decrease by no more than $1.5 million in the next twelve months from the resolution of various uncertain positions as a result of the completion of tax audits, litigation and the expiration of the statute of limitations in various jurisdictions.

DEBT

DEBT	9 Months Ended
	Sep. 30, 2018
DEBT
DEBT	-NOTE 6 – DEBT At September 30, 2018, the Company’s long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.00% – 18.00%, due in monthly and annual installments through 2025 $ 17,521 $ — $ 17,521 Senior unsecured notes 3.2%, due in 2022 75,000 94 74,906 Senior unsecured debts 3.6% floating, equal annual installments through 2022 224,000 578 223,422 Senior unsecured notes 3.5%, due in 2023 125,000 190 124,810 Senior unsecured notes 1.0%, due in 2023 116,095 456 115,639 Senior unsecured notes 3.4%, due in 2024 50,000 80 49,920 Senior unsecured notes 3.5%, due in 2024 100,000 190 99,810 Senior unsecured notes 1.2%, due in 2024 232,190 944 231,246 Senior unsecured notes 3.6%, due in 2025 125,000 215 124,785 Senior unsecured notes 3.6%, due in 2026 125,000 215 124,785 Capital lease obligations 8,932 — 8,932 $ 1,198,738 $ 2,962 $ 1,195,776 Current maturities of long-term obligations (64,039) — (64,039) Total long-term obligations $ 1,134,699 $ 2,962 $ 1,131,737 At December 31, 2017, the Company’s long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.61% – 18.00%, due in monthly and annual installments through 2025 $ 15,349 $ — $ 15,349 Senior unsecured notes 3.2%, due in 2022 75,000 113 74,887 Senior unsecured debts 2.6% floating, equal annual installments through 2022 280,000 692 279,308 Senior unsecured notes 3.5%, due in 2023 125,000 217 124,783 Senior unsecured notes 1.0%, due in 2023 120,095 526 119,569 Senior unsecured notes 3.4%, due in 2024 50,000 89 49,911 Senior unsecured notes 3.5%, due in 2024 100,000 217 99,783 Senior unsecured notes 1.2%, due in 2024 240,190 1,066 239,124 Senior unsecured notes 3.6%, due in 2025 125,000 238 124,762 Senior unsecured notes 3.6%, due in 2026 125,000 238 124,762 Capital lease obligations 741 — 741 $ 1,256,375 $ 3,396 $ 1,252,979 Current maturities of long-term obligations (61,833) — (61,833) Total long-term obligations $ 1,194,542 $ 3,396 $ 1,191,146 Our revolving credit facility and corporate long-term obligations require us to satisfy certain financial and other covenants including: Requirement Level at September 30, 2018 Consolidated Leverage Ratio (1) Maximum of 3.50 to 1.00 2.05 to 1.00 Consolidated Interest Coverage Ratio (1) Minimum of 3.00 to 1.00 12.36 to 1.00 (1) Definitions of ratios are included as part of the revolving credit facility agreement and the private placement agreements. During the third quarter of 2017, the Company entered into the borrowing arrangements summarized below through our wholly-owned United Kingdom subsidiary to better balance our capital structure. Debt Type Amount Term/Maturity Interest Rate Bank term loan $ 280,000 5 year amortizing/July 2022 2.56% floating swapped to 1.36% fixed Bank revolver € 150,000 5 year/July 2022 1.10% floating Private placement € 100,000 6 year/July 2023 0.98% fixed Private placement € 200,000 7 year/July 2024 1.17% fixed The €150 million facility is available to the Company and €89.5 million was utilized as of September 30, 2018. For the nine months ended September 30, 2018, the floating interest rate on the remaining $224 million of the original $280 million bank term loan was 3.60%. The Company also maintains a 5-year revolving credit facility that provides for unsecured financing of up to $300 million and matures in July 2022. We had a $35.0 million outstanding balance under the credit facility at September 30, 2018. No balance was utilized as of December 31, 2017. Credit facility balances are included in Notes Payable, including revolving credit facilities on the Condensed Consolidated Balance Sheet. Aggregate long-term maturities, excluding capital lease obligations, due annually from the current balance sheet date for the next five years are $62,477, $60,379, $58,316, $ 133,284, $117,219 and $758,131 thereafter.

RETIREMENT AND DEFERRED COMPENS

RETIREMENT AND DEFERRED COMPENSATION PLANS	9 Months Ended
	Sep. 30, 2018
RETIREMENT AND DEFERRED COMPENSATION PLANS
RETIREMENT AND DEFERRED COMPENSATION PLANS	NOTE 7 – RETIREMENT AND DEFERRED COMPENSATION PLANS Components of Net Periodic Benefit Cost: Domestic Plans Foreign Plans Three Months Ended September 30, Service cost $ 2,853 $ 2,426 $ 1,457 $ 1,447 Interest cost 1,713 1,752 445 459 Expected return on plan assets (2,803) (2,470) (645) (627) Amortization of net loss 1,214 801 422 493 Amortization of prior service cost — — 122 104 Net periodic benefit cost $ 2,977 $ 2,509 $ 1,801 $ 1,876 Domestic Plans Foreign Plans Nine Months Ended September 30, Service cost $ $ 7,279 $ 4,479 $ 4,166 Interest cost 5,257 1,374 1,321 Expected return on plan assets (7,409) (1,982) (1,781) Amortization of net loss 2,403 1,301 1,400 Amortization of prior service cost — — 376 296 Net periodic benefit cost $ 8,918 $ 7,530 $ 5,548 $ 5,402 The components of net periodic benefit cost, other than the service cost component, are included in the line “Miscellaneous, net” in the income statement. EMPLOYER CONTRIBUTIONS Although the Company has no minimum funding requirement, we contributed $20.0 million to our domestic defined benefit plans during the quarter ended September 30, 2018. We expect to contribute approximately $3.1 million to our foreign defined benefit plans in 2018, and as of September 30, 2018, we have contributed approximately $1.6 million of that amount.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME	9 Months Ended
	Sep. 30, 2018
ACCUMULATED OTHER COMPREHENSIVE INCOME
ACCUMULATED OTHER COMPREHENSIVE INCOME	NOTE 8 – ACCUMULATED OTHER COMPREHENSIVE INCOME Changes in Accumulated Other Comprehensive (Loss) Income by Component: Foreign Defined Benefit Currency Pension Plans Derivatives Total Balance - December 31, 2016 $ (259,888) $ (59,775) $ (46) $ (319,709) Other comprehensive income (loss) before reclassifications 69,493 — (9,237) 60,256 Amounts reclassified from accumulated other comprehensive income — 2,699 5,667 8,366 Net current-period other comprehensive income 69,493 2,699 (3,570) 68,622 Balance - September 30, 2017 $ (190,395) $ (57,076) $ (3,616) $ (251,087) Balance - December 31, 2017 $ (185,503) $ (64,595) $ (3,204) $ (253,302) Other comprehensive income (loss) before reclassifications (53,141) — 12,507 (40,634) Amounts reclassified from accumulated other comprehensive income — 4,032 (11,444) (7,412) Net current-period other comprehensive income (53,141) 4,032 1,063 (48,046) Balance - September 30, 2018 $ (238,644) $ (60,563) $ (2,141) $ (301,348) Reclassifications Out of Accumulated Other Comprehensive (Loss) Income: Amount Reclassified from Details about Accumulated Other Accumulated Other Affected Line in the Statement Comprehensive Income Components Comprehensive Income Where Net Income is Presented Three Months Ended September 30, Defined Benefit Pension Plans Amortization of net loss $ 1,636 $ 1,294 (1) Amortization of prior service cost 122 104 (1) 1,758 1,398 Total before tax (425) (474) Tax benefit $ 1,333 $ 924 Net of tax Derivatives Changes in treasury locks $ 4 $ 11 Interest Expense Changes in cross currency swap: interest component (1,337) (678) Interest Expense Changes in cross currency swap: foreign exchange component (2,131) 7,481 Miscellaneous, net (3,464) 6,814 Total before tax 588 (1,161) Tax benefit $ (2,876) $ 5,653 Net of tax Total reclassifications for the period $ (1,543) $ 6,577 Amount Reclassified from Details about Accumulated Other Accumulated Other Affected Line in the Statement Comprehensive Income Components Comprehensive Income Where Net Income is Presented Nine Months Ended September 30, Defined Benefit Pension Plans Amortization of net loss $ 4,943 $ 3,803 (1) Amortization of prior service cost 376 296 (1) 5,319 4,099 Total before tax (1,287) (1,400) Tax benefit $ 4,032 $ 2,699 Net of tax Derivatives Changes in treasury locks $ 26 $ 32 Interest Expense Changes in cross currency swap: interest component (3,824) (678) Interest Expense Changes in cross currency swap: foreign exchange component (9,984) 7,481 Miscellaneous, net (13,782) 6,835 Total before tax 2,338 (1,168) Tax benefit $ (11,444) $ 5,667 Net of tax Total reclassifications for the period $ (7,412) $ 8,366 (1) These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 7 – Retirement and Deferred Compensation Plans for additional details).

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	9 Months Ended
	Sep. 30, 2018
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	NOTE 9 – DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES The Company maintains a foreign exchange risk management policy designed to establish a framework to protect the value of the Company’s non-functional denominated transactions from adverse changes in exchange rates. Sales of the Company’s products can be denominated in a currency different from the currency in which the related costs to produce the product are denominated. Changes in exchange rates on such inter-country sales or intercompany loans can impact the Company’s results of operations. The Company’s policy is not to engage in speculative foreign currency hedging activities, but to minimize our net foreign currency transaction exposure, defined as firm commitments and transactions recorded and denominated in currencies other than the functional currency. The Company may use foreign currency forward exchange contracts, options and cross currency swaps to economically hedge these risks. For derivative instruments designated as hedges, the Company formally documents the nature and relationships between the hedging instruments and the hedged items, as well as the risk management objectives, strategies for undertaking the various hedge transactions, and the method of assessing hedge effectiveness at inception. Quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item. Additionally, in order to designate any derivative instrument as a hedge of an anticipated transaction, the significant characteristics and expected terms of any anticipated transaction must be specifically identified, and it must be probable that the anticipated transaction will occur. All derivative financial instruments used as hedges are recorded at fair value in the Condensed Consolidated Balance Sheets (see Note 10 - Fair Value). CASH FLOW HEDGE For derivative instruments that are designated and qualify as cash flow hedges, the changes in fair values are recorded in accumulated other comprehensive loss and included in changes in derivative gain/loss. The changes in the fair values of derivatives designated as cash flow hedges are reclassified from accumulated other comprehensive loss to net income when the underlying hedged item is recognized in earnings. Cash flows from the settlement of derivative contracts designated as cash flow hedges offset cash flows from the underlying hedged items and are included in operating activities in the Condensed Consolidated Statements of Cash Flows. As disclosed in Note 6 – Long-Term Obligations, our wholly-owned UK subsidiary borrowed $280 million in term loan borrowings under a new credit facility. In order to mitigate the currency risk of U.S. dollar debt on a euro functional currency entity and to mitigate the risk of variability in interest rates, we entered into a EUR/USD floating-to-fixed cross currency swap on July 20, 2017 in the notional amount of $280 million to effectively hedge the foreign exchange and interest rate exposure on the $280 million term loan. Related to this hedge, approximately $2.1 million of net after-tax loss is included in accumulated other comprehensive earnings at September 30, 2018. The amount expected to be recognized into earnings during the next 12 months related to the interest component of our cross currency swap based on prevailing foreign exchange and interest rates at September 30, 2018 is $4.8 million. The amount expected to be recognized into earnings during the next 12 months related to the foreign exchange component of our cross currency swap is dependent on fluctuations in currency exchange rates. As of September 30, 2018, the fair value of the cross currency swap was a $4.7 million liability. The swap contract expires on July 20, 2022. HEDGE OF NET INVESTMENTS IN FOREIGN OPERATIONS A significant number of the Company’s operations are located outside of the United States. Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of the Company’s foreign subsidiaries. A strengthening U.S. dollar relative to foreign currencies has a dilutive translation effect on the Company’s financial condition and results of operations. Conversely, a weakening U.S. dollar has an additive effect. The Company in some cases maintains debt in these subsidiaries to offset the net asset exposure. The Company does not otherwise actively manage this risk using derivative financial instruments. In the event the Company plans on a full or partial liquidation of any of our foreign subsidiaries where the Company’s net investment is likely to be monetized, the Company will consider hedging the currency exposure associated with such a transaction. OTHER As of September 30, 2018, the Company has recorded the fair value of foreign currency forward exchange contracts of $0.3 million in prepaid and other and $0.9 million in accounts payable and accrued liabilities on the balance sheet. All forward exchange contracts outstanding as of September 30, 2018 had an aggregate contract amount of $103.9 million. Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets as of September 30, 2018 and December 31, 2017 September 30, 2018 December 31, 2017 Derivatives Derivatives Derivatives not Derivatives not Designated Designated Designated Designated Balance Sheet as Hedging as Hedging as Hedging as Hedging Location Instruments Instruments Instruments Instruments Derivative Assets Foreign Exchange Contracts Prepaid and other $ — $ 262 $ — $ 663 $ — $ 262 $ — $ 663 Derivative Liabilities Foreign Exchange Contracts Accounts payable and accrued liabilities $ — $ 881 $ — $ 1,604 Cross Currency Swap Contract (1) Accounts payable and accrued liabilities 4,712 — 16,309 — $ 4,712 $ 881 $ 16,309 $ 1,604 (1) This cross currency swap contract is composed of both an interest component and a foreign exchange component. The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Quarters Ended September 30, 2018 and 2017 Amount of Gain (Loss) Total Amount Amount of Gain (Loss) Location of (Loss) Reclassified from of Affected Derivatives in Cash Recognized in Gain Recognized Accumulated Income Flow Hedging Other Comprehensive in Income on Other Comprehensive Statement Relationships Income on Derivative Derivatives Income on Derivative Line Item Cross currency swap contract: Interest component $ (68) $ (3,648) Interest expense $ 1,337 $ 678 $ (8,735) Foreign exchange component 2,131 (7,481) Miscellaneous, net 2,131 (7,481) (2,928) $ 2,063 $ (11,129) $ 3,468 $ (6,803) $ (11,663) The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Nine Months Ended September 30, 2018 and 2017 Amount of Gain (Loss) Total Amount Amount of Gain (Loss) Location of (Loss) Reclassified from of Affected Derivatives in Cash Recognized in Gain Recognized Accumulated Income Flow Hedging Other Comprehensive in Income on Other Comprehensive Statement Relationships Income on Derivative Derivatives Income on Derivative Line Item Cross currency swap contract: Interest component $ 5,084 $ (3,648) Interest expense $ 3,824 $ 678 $ (24,754) Foreign exchange component 9,984 (7,481) Miscellaneous, net 9,984 (7,481) (4,372) $ 15,068 $ (11,129) $ 13,808 $ (6,803) $ (29,126) The Effect of Derivatives Not Designated as Hedging Instruments on the Condensed Consolidated Statements of Income for the Quarters Ended September 30, 2018 and 2017 Amount of (Loss) Gain Derivatives Not Designated Location of (Loss) Gain Recognized Recognized in Income as Hedging Instruments in Income on Derivatives on Derivatives Foreign Exchange Contracts Other (Expense) Income: $ (1,011) $ (15,534) $ (1,011) $ (15,534) The Effect of Derivatives Not Designated as Hedging Instruments on the Condensed Consolidated Statements of Income for the Nine Months Ended September 30, 2018 and 2017 Amount of (Loss) Gain Derivatives Not Designated Location of (Loss) Gain Recognized Recognized in Income as Hedging Instruments in Income on Derivatives on Derivatives Foreign Exchange Contracts Other (Expense) Income: $ 102 $ (64,651) $ 102 $ (64,651) Gross Amounts not Offset Gross Amounts Net Amounts in the Statement of Offset in the Presented in Financial Position Gross Statement of the Statement of Financial Cash Collateral Net Amount Financial Position Financial Position Instruments Received Amount Description September 30, 2018 Derivative Assets $ 262 — $ 262 — — $ 262 Total Assets $ 262 — $ 262 — — $ 262 Derivative Liabilities $ 5,593 — $ 5,593 — — $ 5,593 Total Liabilities $ 5,593 — $ 5,593 — — $ 5,593 December 31, 2017 Derivative Assets $ 663 — $ 663 — — $ 663 Total Assets $ 663 — $ 663 — — $ 663 Derivative Liabilities $ 17,913 — $ 17,913 — — $ 17,913 Total Liabilities $ 17,913 — $ 17,913 — — $ 17,913

FAIR VALUE

FAIR VALUE	9 Months Ended
	Sep. 30, 2018
FAIR VALUE
FAIR VALUE	NOTE 10 – FAIR VALUE Authoritative guidelines require the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: · Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities. · Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. · Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability. As of September 30, 2018, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 262 $ — $ 262 $ — Total assets at fair value $ 262 $ — $ 262 $ — Liabilities Foreign exchange contracts (1) $ 881 $ — $ 881 $ — Cross currency swap contract (1) 4,712 — 4,712 — Total liabilities at fair value $ 5,593 $ — $ 5,593 $ — As of December 31, 2017, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 663 $ — $ 663 $ — Total assets at fair value $ 663 $ — $ 663 $ — Liabilities Foreign exchange contracts (1) $ 1,604 $ — $ 1,604 $ — Cross currency swap contract (1) 16,309 — 16,309 — Total liabilities at fair value $ 17,913 $ — $ 17,913 $ — (1) Market approach valuation technique based on observable market transactions of spot and forward rates. The carrying amounts of the Company’s other current financial instruments such as cash and equivalents, accounts and notes receivable, notes payable and current maturities of long-term obligations approximate fair value due to the short-term maturity of the instruments. The Company considers our long-term obligations a Level 2 liability and utilizes the market approach valuation technique based on interest rates that are currently available to the Company for issuance of debt with similar terms and maturities. The estimated fair value of the Company’s long-term obligations was $1.1 billion as of September 30, 2018 and December 31, 2017. As discussed in Note 17 - Acquisitions, the Company has a contingent consideration obligation to the selling shareholders of Reboul SAS (“Reboul”) in connection with the Reboul Acquisition (as defined herein) based on 2018 earnings before net interest, taxes, depreciation and amortization (“EBITDA”). We consider this a Level 3 liability; however, we estimated the aggregate fair value for this contingent consideration arrangement to be zero as of September 30, 2018.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2018
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 11 - COMMITMENTS AND CONTINGENCIES The Company, in the normal course of business, is subject to a number of lawsuits and claims both actual and potential in nature. While management believes the resolution of these claims and lawsuits will not have a material adverse effect on the Company’s financial position or results of operations or cash flows, claims and legal proceedings are subject to inherent uncertainties, and unfavorable outcomes could occur and could include amounts in excess of any accruals which management has established. Were such unfavorable final outcomes to occur, it is possible that they could have a material adverse effect on our financial position, results of operations and cash flows. Under our Certificate of Incorporation, the Company has agreed to indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a directors and officers liability insurance policy that covers a portion of our exposure. As a result of our insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company has no liabilities recorded for these agreements as of September 30, 2018 and December 31, 2017. An environmental investigation, undertaken to assess areas of possible contamination, was completed at the Company’s facility in Jundiaí, São Paulo, Brazil. The facility is primarily an internal supplier of anodized aluminum components for certain of our dispensing systems. The testing indicated that soil and groundwater in certain areas of the facility were impacted above acceptable levels established by local regulations. In March 2017, the Company reported the findings to the relevant environmental authority, the Environmental Company of the State of São Paulo (“CETESB”). The Company continues to monitor and test the affected areas to determine the full extent of the impact and the scope of any required remediation. Initial costs for further investigation and possible remediation, which are based on assumptions about the area of impact and customary remediation costs, are estimated to be in the range of $1.5 million to $3.0 million. The range of possible loss associated with this environmental contingency is subject to considerable uncertainty due to the incomplete status of the investigation and ongoing review of the CETESB. We will continue to evaluate the range of likely costs as the investigation proceeds and we have further clarity on the nature and extent of remediation that will be required. We note that the contamination, or any failure to complete any required remediation in a timely manner, could potentially result in fines or penalties. We accrued $1.5 million (operating expense) in the first quarter of 2017 relating to this contingency. The amount is periodically reviewed, and adjusted as necessary, as the matter continues to evolve. Based on the current status of the investigation, no adjustment to the accrual was necessary for the quarter ended September 30, 2018. Also, during the quarter ended June 30, 2018, the Company recorded a $750 thousand accrual for a potential environmental matter at a U.S. manufacturing site. This matter was remediated and settled during the third quarter of 2018 for $239 thousand. The remaining accrual has been released during the third quarter of 2018.

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAM	9 Months Ended
	Sep. 30, 2018
STOCK REPURCHASE PROGRAM
STOCK REPURCHASE PROGRAM	NOTE 12 – STOCK REPURCHASE PROGRAM On October 20, 2016, the Company announced a share repurchase authorization of up to $350 million of common stock. This authorization replaces previous authorizations and has no expiration date. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. During the nine months ended September 30, 2018, the Company repurchased approximately 668 thousand shares for approximately $61.7 million. We did not repurchase any shares during the quarter ended September 30, 2018. During the three and nine months ended September 30, 2017, the Company repurchased approximately 546 thousand and 1.4 million shares for approximately $45.5 million and $113.3 million, respectively. As of September 30, 2018, there was $80.2 million of authorized share repurchases available to the Company.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Sep. 30, 2018
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION	NOTE 13 – STOCK-BASED COMPENSATION The Company issues stock options and restricted stock units (“RSUs”), which consist of time-based and performance-based awards, to employees under stock awards plans approved by stockholders. In addition, RSUs are issued to non-employee directors under a Restricted Stock Unit Award Agreement for Directors pursuant to the 2018 Equity Incentive Plan. Previously, non-employee directors were issued stock options under a Director Stock Option Plan. Stock options are awarded with the exercise price equal to the market price on the date of grant and generally vest over three years and expire 10 years after grant. RSUs granted to employees vest according to a specified performance period and/or vesting period. Time-based RSUs generally vest over three years. Performance-based RSUs vest at the end of the specified performance period, generally three years, assuming required performance or market vesting conditions are met. Performance-based RSUs have one of two vesting conditions: (1) based on Aptar’s internal financial performance metrics and (2) based on Aptar’s total shareholder return (“TSR”) relative to total shareholder returns of an industrial peer group, subject to discretion if the overall TSR is negative at the conclusion of the performance period. At the time of vesting, Aptar will issue or cause to be issued in the employee’s name the vested shares of common stock. In addition, RSU awards are generally net settled (shares are withheld to cover the employee tax obligation). Director RSUs are only time-based, and generally vest over one year. Compensation expense attributable to employee stock options for the first nine months of 2018 was approximately $8.9 million ($6.9 million after tax). The income tax benefit related to this compensation expense was approximately $2.0 million. Approximately $7.1 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales. Compensation expense attributable to stock options for the first nine months of 2017 was approximately $12.6 million ($8.6 million after tax). The income tax benefit related to this compensation expense was approximately $4.0 million. Approximately $11.0 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales. The Company uses historical data to estimate expected life and volatility. The weighted-average fair value of stock options granted under the Stock Awards Plans was $14.82 and $11.86 per share during the first nine months of 2018 and 2017, respectively. These values were estimated on the respective grant dates using the Black-Scholes option-pricing model with the following weighted-average assumptions: Stock Awards Plans: Nine Months Ended September 30, Dividend Yield 1.5 % 1.7 % Expected Stock Price Volatility 14.2 % 15.8 % Risk-free Interest Rate 2.8 % 2.2 % Expected Life of Option (years) 6.6 6.7 A summary of option activity under the Company’s stock plans during the nine months ended September 30, 2018 is presented below: Stock Awards Plans Director Stock Option Plans Weighted Average Weighted Average Options Exercise Price Options Exercise Price Outstanding, January 1, 2018 8,059,319 $ 61.67 214,967 $ 57.44 Granted 603,901 88.39 — — Exercised (1,439,333) 52.69 (57,767) 55.71 Forfeited or expired (243,110) 74.32 — — Outstanding at September 30, 2018 6,980,777 $ 65.39 157,200 $ 58.08 Exercisable at September 30, 2018 5,114,822 $ 60.65 157,200 $ 58.08 Weighted-Average Remaining Contractual Term (Years): Outstanding at September 30, 2018 6.0 4.3 Exercisable at September 30, 2018 5.2 4.3 Aggregate Intrinsic Value: Outstanding at September 30, 2018 $ 295,630 $ 7,807 Exercisable at September 30, 2018 $ 240,839 $ 7,807 Intrinsic Value of Options Exercised During the Nine Months Ended: September 30, 2018 $ 62,895 $ 2,187 September 30, 2017 $ 44,734 $ 1,995 The grant date fair value of options vested during the nine months ended September 30, 2018 and 2017 was $16.5 million and $16.9 million, respectively. Cash received from option exercises was approximately $78.9 million and the actual tax benefit realized for the tax deduction from option exercises was approximately $15.5 million in the nine months ended September 30, 2018. As of September 30, 2018, the remaining valuation of stock option awards to be expensed in future periods was $10.7 million and the related weighted-average period over which it is expected to be recognized is 1.7 years. The fair value of both time-based RSUs and performance-based RSUs pertaining to internal performance metrics is determined using the closing price of our common stock on the grant date. The fair value of performance-based RSUs pertaining to TSR is estimated using a Monte Carlo simulation. Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement. Nine Months Ended September 30, Fair value per stock award $ 128.70 Measurement date stock price $ 89.42 Assumptions: Aptar's stock price expected volatility 12.30 % Expected average volatility of peer companies 27.50 % Correlation assumption 20.20 % Risk-free interest rate 2.42 % Dividend yield assumption 1.43 % A summary of RSU activity as of September 30, 2018, and changes during the nine month period then ended, is presented below: Time-Based RSUs Performance-Based RSUs Weighted Average Weighted Average Units Grant-Date Fair Value Units Grant-Date Fair Value Nonvested at January 1, 2018 124,067 $ 74.65 — $ — Granted 187,502 96.26 80,843 111.55 Vested (33,882) 75.57 — — Forfeited (31,672) 78.62 (9,762) 111.55 Nonvested at September 30, 2018 246,015 $ 90.48 71,081 $ 111.55 Included in the September 30, 2018 time-based RSUs are 14,257 units awarded to non-employee directors and 14,793 units vested related to non-employee directors. Compensation expense recorded attributable to RSUs for the first nine months of 2018 and 2017 was approximately $5.9 million and $2.4 million, respectively. The actual tax benefit realized for the tax deduction from RSUs was approximately $718 thousand in the nine months ended September 30, 2018. The fair value of units vested during the nine months ended September 30, 2018 and 2017 was $2.6 million and $4.7 million, respectively. The intrinsic value of units vested during the nine months ended September 30, 2018 and 2017 was $3.1 million and $5.2 million, respectively. As of September 30, 2018, there was $23.2 million of total unrecognized compensation cost relating to RSU awards which is expected to be recognized over a weighted-average period of 2.4 years. The Company has a long-term incentive program for certain employees. Each award is based on the cumulative TSR of our common stock during a three-year performance period compared to a peer group. The total expected expense related to this program for awards outstanding as of September 30, 2018 is approximately $3.7 million, of which $1.8 million and $1.5 million was recognized in the first nine months of 2018 and 2017, respectively.

EARNINGS PER SHARE

EARNINGS PER SHARE	9 Months Ended
	Sep. 30, 2018
EARNINGS PER SHARE
EARNINGS PER SHARE	NOTE 14 – EARNINGS PER SHARE Basic net income per share is calculated by dividing net income attributable to Aptar by the weighted-average number of common shares outstanding during the period. Diluted net income per share is calculated by dividing the net income attributable to Aptar by the weighted-average number of common and common equivalent shares outstanding during the applicable period. The difference between basic and diluted earnings per share is attributable to stock-based compensation awards. Stock-based compensation awards for which total employee proceeds exceed the average market price over the applicable period would have an antidilutive effect on earnings per share, and accordingly, are excluded from the calculation of diluted earnings per share. The reconciliation of basic and diluted earnings per share for the three and nine months ended September 30, 2018 and 2017 is as follows: Three Months Ended September 30, 2018 September 30, 2017 Diluted Basic Diluted Basic Consolidated operations Income available to common stockholders $ 38,996 $ 38,996 $ 53,523 $ 53,523 Average equivalent shares Shares of common stock 62,378 62,378 62,592 62,592 Effect of dilutive stock based compensation Stock options 2,659 — 2,171 — Restricted stock 92 — 58 — Total average equivalent shares 65,129 62,378 64,821 62,592 Net income per share $ 0.60 $ 0.63 $ 0.83 $ 0.86 Nine Months Ended September 30, 2018 September 30, 2017 Diluted Basic Diluted Basic Consolidated operations Income available to common stockholders $ 154,071 $ 154,071 $ 170,517 $ 170,517 Average equivalent shares Shares of common stock 62,304 62,304 62,527 62,527 Effect of dilutive stock-based compensation Stock options 2,440 — 2,046 — Restricted stock 78 — 53 — Total average equivalent shares 64,822 62,304 64,626 62,527 Net income per share $ 2.38 $ 2.47 $ 2.64 $ 2.73

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Sep. 30, 2018
SEGMENT INFORMATION
SEGMENT INFORMATION	NOTE 15 – SEGMENT INFORMATION The Company is organized into three reporting segments. Operations that sell dispensing systems and sealing solutions primarily to the personal care, beauty and home care markets form the Beauty + Home segment. Operations that sell dispensing systems, sealing and active packaging solutions primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment. Operations that sell dispensing systems and sealing solutions primarily to the food and beverage markets form the Food + Beverage segment. CSP Technologies’ financial results are reported in the Pharma and Food + Beverage segments. The accounting policies of the segments are the same as those described in Part II, Item 8, Note 1 - Summary of Significant Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. In order to more closely align with how the markets analyze our segment results, we have changed our non-U.S. GAAP segment measure of profitability from Segment Income to Adjusted EBITDA beginning in 2018. All internal segment reporting and discussions of results with our Chief Operating Decision Maker (CODM) are now based on segment Adjusted EBITDA. All references to segment profitability have been updated for this change. Financial information regarding the Company’s reporting segments is shown below: Three Months Ended September 30, Nine Months Ended September 30, Total Sales: Beauty + Home $ 346,040 $ 338,068 $ 1,103,664 $ 992,476 Pharma 227,691 199,551 699,105 598,168 Food + Beverage 97,297 91,852 294,362 269,159 Total Sales 671,028 629,471 2,097,131 1,859,803 Less: Intersegment Sales: Beauty + Home $ 4,280 $ 4,320 $ 15,195 $ 14,163 Pharma 176 4 254 7 Food + Beverage 797 821 1,949 2,245 Total Intersegment Sales $ 5,253 $ 5,145 $ 17,398 $ 16,415 Net Sales: Beauty + Home $ 341,760 $ 333,748 $ 1,088,469 $ 978,313 Pharma 227,515 199,547 698,851 598,161 Food + Beverage 96,500 91,031 292,413 266,914 Net Sales $ 665,775 $ 624,326 $ 2,079,733 $ 1,843,388 Adjusted EBITDA (1): Beauty + Home $ 42,174 $ 42,627 $ 141,155 $ 129,265 Pharma 84,516 66,260 250,709 204,750 Food + Beverage 15,482 18,116 46,284 49,756 Corporate & Other, unallocated (7,954) (8,778) (28,576) (26,924) Acquisition-related costs (2) (10,369) — (12,932) — Restructuring Initiatives (3) (23,852) — (48,002) — Depreciation and amortization (41,857) (40,087) (123,133) (114,660) Interest Expense (8,735) (9,733) (24,754) (25,707) Interest Income 1,537 1,113 6,306 2,086 Income before Income Taxes $ 50,942 $ 69,518 $ 207,057 $ 218,566 (1) The Company evaluates performance of our business units and allocates resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring and acquisition-related costs. (2) Acquisition-related costs include transaction costs and purchase accounting adjustments related to inventory for acquisitions (see Note 17 – Acquisitions for further details). (3) Restructuring Initiatives includes expense items for the three and nine months ended September 30, 2018 as follows (see Note 18 – Restructuring Initiatives for further details): Three Months Ended September 30, Nine Months Ended September 30, Restructuring Initiatives by Segment Beauty + Home $ 18,854 $ — $ 38,501 $ — Pharma 2,008 — 3,596 — Food + Beverage 2,638 — 4,307 — Corporate & Other 352 — 1,598 — Total Restructuring Initiatives $ 23,852 $ — $ 48,002 $ —

INSURANCE SETTLEMENT RECEIVABLE

INSURANCE SETTLEMENT RECEIVABLE	9 Months Ended
	Sep. 30, 2018
INSURANCE SETTLEMENT RECEIVABLE
INSURANCE SETTLEMENT RECEIVABLE	Note 16 – INSURANCE SETTLEMENT RECEIVABLE A fire caused damage to Aptar’s facility in Annecy, France in June 2016. The fire was contained to one of three production units and there were no reported injuries. Aptar Annecy supplies anodized aluminum components for certain Aptar dispensing systems. While repairs are underway, Aptar sources from its network of suppliers as well as from its anodizing facility in Brazil. The Company is insured for the damages caused by the fire, including business interruption insurance, and it does not expect this incident to have a material impact on its financial results. Losses related to the fire of $3.2 million and $14.1 million were incurred during the three and nine months ended September 30, 2018, respectively. Losses related to the fire of $4.5 million and $14.4 million were incurred during the three and nine months ended September 30, 2017, respectively. For the nine months ended September 30, 2018, we received insurance proceeds of $24.2 million, and have no insurance receivable as of September 30, 2018. In many cases, our insurance coverage exceeds the amount of these recognized losses. However, no gain contingencies were recognized during the three or nine months ended September 30, 2018 as our ability to realize those gains remains uncertain. Profitability was negatively impacted by $1.5 million and $4.4 million related to the Annecy fire during the three and nine months ended September 30, 2018, respectively. These 2018 losses negatively impacted the Beauty + Home and Pharma segments by $0.5 million and $1.0 million, respectively, in the third quarter of 2018. Profitability was negatively impacted by $1.4 million and $4.1 million related to the Annecy fire during the three and nine months ended September 30, 2017, respectively. These 2017 losses negatively impacted the Beauty + Home segment.

ACQUISITIONS

ACQUISITIONS	9 Months Ended
	Sep. 30, 2018
ACQUISITIONS
ACQUISITIONS	NOTE 17 – ACQUISITIONS On August 27, 2018, the Company completed its acquisition (the “CSP Technologies Acquisition”) of all of the outstanding capital stock of CSP Technologies S.à r.l. (“CSP Technologies”). CSP Technologies is a leader in active packaging technology based on proprietary material science expertise for the pharma and food service markets. CSP Technologies operates two manufacturing locations in the U.S. and one in France. The purchase price was approximately $553.5 million and was funded by cash on hand. $5 million is currently held in restricted cash pending the finalization of a working capital adjustment expected to be completed within 75 days after closing. CSP Technologies contributed net sales of $13.2 million and pretax loss of $1.9 million for the quarter ended September 30, 2018. Sales of $9.4 million and $3.8 million were reported in the Pharma and Food + Beverage segments, respectively, for the quarter ended September 30, 2018. Pretax losses of $1.8 million and $0.1 million were reported in the Pharma and Food + Beverage segments, respectively, for the quarter ended September 30, 2018. The pretax loss for the quarter includes $3.3 million of fair value adjustment amortization for inventory sold during the quarter. The aforementioned purchase accounting adjustments and amounts included in the following tables are provisional, as the Company is in the process of finalizing purchase accounting. The Company recognized $7.1 million and $9.0 million in transaction costs related to the acquisition of CSP Technologies for the three and nine months ended September 30, 2018, respectively. These costs are reflected in the selling, research & development and administration section of the Consolidated Statements of Income and within Corporate & Other as disclosed in Note 15 – Segment Information. The following table summarizes the assets acquired and liabilities assumed as of the acquisition date at estimated fair value. August 27, 2018 Assets Cash and equivalents $ 24,053 Accounts receivable 21,250 Inventories 45,500 Prepaid and other 2,925 Property, plant and equipment 101,579 Goodwill 261,216 Intangible assets 198,200 Other miscellaneous assets 980 Liabilities Current maturities of long-term obligations 129 Accounts payable and accrued liabilities 30,871 Long-term obligations 6,037 Deferred income taxes 47,504 Retirement and deferred compensation plans 212 Deferred and other non-current liabilities 17,492 Net assets acquired $ 553,458 The following table is a summary of the fair value estimates of the acquired identifiable intangible assets and weighted-average useful lives as of the acquisition date: Weighted-Average Estimated Useful Life Fair Value (in years) of Asset Acquired technology $ 46,700 Customer relationships 132,300 Trademarks and trade names 14,600 License agreements and other 4,600 Total $ 198,200 Goodwill in the amount of $261.2 million was recorded for the CSP Technologies Acquisition, of which $154.8 million and $106.4 million is included in the Pharma and Food + Beverage segments, respectively. Goodwill is calculated as the excess of the consideration transferred over the net assets acquired and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Goodwill largely consists of leveraging the Company’s commercial presence in selling the CSP Technologies line of products in markets where CSP Technologies did not previously operate and the ability of CSP Technologies to maintain its competitive advantage from a technical viewpoint. Goodwill will not be amortized, but will be tested for impairment at least annually. We do not expect any of the goodwill will be deductible for tax purposes. The unaudited pro forma results presented below include the effects of the CSP Technologies Acquisition as if it had occurred as of January 1, 2017. The unaudited pro forma results reflect certain adjustments related to the acquisition, such as intangible asset amortization, fair value adjustments for inventory and financing costs related to the change in our debt structure. Pro forma earnings were adjusted to exclude $14.2 million after tax ($18.5 million pretax) and $16.6 million after tax ($21.9 million pretax) of transaction and other costs for the three and nine months ended September 30, 2018, respectively. The aforementioned costs include compensation, consulting, legal and advisory fees. Pro forma earnings were also adjusted to exclude $2.6 million after tax ($3.3 million pretax) of nonrecurring expense related to the fair value adjustment to acquisition-date inventory for both the three and nine months ended September 30, 2018. The pro forma results do not include any synergies or other expected benefits of the acquisition. Accordingly, the unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the acquisition been completed on the date indicated. Three Months Ended September 30, Nine Months Ended September 30, Net Sales $ 687,201 $ 659,741 $ 2,172,737 $ 1,943,297 Net Income Attributable to AptarGroup Inc. 48,034 57,829 158,527 168,028 Net Income per common share — basic 0.77 0.92 2.54 2.69 Net Income per common share — diluted 0.74 0.89 2.45 2.60 On May 1, 2018, the Company acquired 100% of the common stock of Reboul, a French manufacturer specializing in stamping, decorating and assembling metal and plastic packaging for the cosmetics and luxury markets, for an initial purchase price of approximately $3.6 million (exclusive of $112 thousand of cash acquired) (the “Reboul Acquisition”). The results of Reboul’s operations have been included in the consolidated financial statements within our Beauty + Home segment since the date of acquisition. As part of the Reboul Acquisition, we may be obligated to pay to the selling shareholders of Reboul certain contingent consideration based on 2018 EBITDA as defined in the purchase agreement. Based on projections as of the acquisition date, we estimated the aggregate fair value for this contingent consideration arrangement to be zero. In May 2018, the Company invested $10.0 million in preferred equity stock of Reciprocal Labs Corporation, doing business as Propeller Health, which is accounted for at cost, consistent with measurement alternative guidance described in Note 1 above. There were no indications of impairment nor were there any changes resulting from observable price changes noted in the three and nine months ended September 30, 2018. In February 2017, the Company acquired a 20% minority investment in Kali Care, Inc. (“Kali Care”) for $5.0 million. Kali Care is a Silicon Valley-based technology company that provides digital monitoring systems for ophthalmic medication. Kali Care’s sensing technology allows clinicians to collect real-time compliance data, and is a powerful tool for ophthalmologists in managing the care of their patients, and represents an additional investment into connected devices for our Pharma applications. This investment is being accounted for under the equity method of accounting from the date of acquisition.

RESTRUCTURING INITIATIVES

RESTRUCTURING INITIATIVES	9 Months Ended
	Sep. 30, 2018
RESTRUCTURING INITIATIVES.
RESTRUCTURING INITIATIVES	NOTE 18 – RESTRUCTURING INITIATIVES In late 2017, Aptar began a business transformation to drive profitable sales growth, increase operational excellence, enhance our approach to innovation and improve organizational effectiveness. The primary focus of the plan is the Beauty + Home segment; however, certain global general and administrative functions will also be addressed. For the three and nine months ended September 30, 2018, the Company recognized $23.9 million and $48.0 million of restructuring costs related to this plan, respectively. The Company estimates total implementation costs of approximately $90 million over the next three years. The Company also anticipates making capital investments related to the business transformation of approximately $54 million of which the majority will be in 2018. As of September 30, 2018 the Company has recorded the following activity associated with the business transformation: Beginning Net Charges for Ending Reserve at the Nine Months Reserve at 12/31/2017 Ended 9/30/2018 Cash Paid FX Impact 9/30/2018 Employee severance $ 2,258 $ 2,035 $ (2,414) $ (52) $ 1,827 Professional fees and other costs — 45,967 (35,033) 637 11,571 Totals $ 2,258 $ 48,002 $ (37,447) $ 585 $ 13,398

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2018
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of AptarGroup, Inc. and our subsidiaries. The terms “AptarGroup”, “Aptar” or “Company” as used herein refer to AptarGroup, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated. Certain previously reported amounts have been reclassified to conform to the current period presentation. In the opinion of management, the unaudited Condensed Consolidated Financial Statements (the “Condensed Consolidated Financial Statements”) include all normal recurring adjustments necessary for a fair statement of consolidated financial position, results of operations, comprehensive income, changes in equity and cash flows for the interim periods presented. The accompanying Condensed Consolidated Financial Statements have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information presented not misleading. Also, certain financial position data included herein was derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 but does not include all disclosures required by U.S. GAAP. Accordingly, these Condensed Consolidated Financial Statements and related notes should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. The results of operations of any interim period are not necessarily indicative of the results that may be expected for the year. During the quarter ended June 30, 2018, primarily based on published estimates, which indicate that Argentina's three-year cumulative inflation rate has exceeded 100%, we concluded that Argentina has become a highly inflationary economy. Beginning July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiaries. We have changed the functional currency from the Argentinian peso to the U.S. dollar. Local currency monetary assets and liabilities have been remeasured into U.S. dollars using exchange rates as of the latest balance sheet date, with remeasurement adjustments and other transaction gains and losses recognized in net earnings. During the third quarter of 2018, we recognized approximately $1.0 million of additional losses due to these changes. Our Argentinian operations contributed approximately 2.0% of consolidated net assets and revenues at and for the nine months ended September 30, 2018.
ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS	ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification. In May 2014, the FASB issued ASU 2014-09, which amended the guidance for recognition of revenue from customer contracts. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. On January 1, 2018, we adopted this standard and all the related amendments (the “new revenue standard”) for all contracts. This adoption was accounted for using the modified retrospective method. We recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the January 1, 2018 opening balance of retained earnings. Comparative information for the prior periods has not been restated and continues to be reported under the accounting standards in effect prior to January 1, 2018. Balance at Balance at December 31, 2017 Adjustment January 1, 2018 Consolidated Balance Sheets Assets Inventories $ 337,216 $ (14,637) $ 322,579 Prepaid and other 109,791 13,984 123,775 Liabilities Accounts payable and accrued liabilities 461,579 (5,706) 455,873 Deferred income taxes 20,995 1,292 22,287 Deferred and other non-current liabilities 5,608 824 6,432 Stockholders’ Equity Retained earnings 1,301,147 2,937 1,304,084 A majority of our sales revenue continues to be recognized when products are shipped from our manufacturing facilities. For certain custom product and tooling sales where revenue was previously recognized when the products were shipped, we now recognize revenue over the time required to manufacture the product or build the tool in accordance with the new revenue standard. We also have certain extended warranty contracts, which under the new standard are considered a separate performance obligation and are required to be deferred and recognized into revenue over the life of the agreement. In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated statements of income and balance sheets is as follows: For the Three Months Ended September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 341,760 $ 340,787 $ 973 Pharma 227,515 227,526 (11) Food + Beverage 96,500 96,478 22 Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 435,379 434,601 778 Provision for income taxes 11,920 11,866 54 Net income 39,022 38,870 152 For the Nine Months Ended September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 1,088,469 $ 1,087,922 $ 547 Pharma 698,851 699,299 (448) Food + Beverage 292,413 292,437 (24) Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 1,355,445 1,354,844 601 Provision for income taxes 52,966 53,138 (172) Net income 154,091 154,445 (354) September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Balance Sheets Assets Inventories $ 394,264 $ 409,502 $ (15,238) Prepaid and other 118,613 102,767 15,846 Liabilities Accounts payable and accrued liabilities 524,528 528,081 (3,553) Deferred income taxes 48,857 47,737 1,120 Deferred and other non-current liabilities 24,837 24,379 458 Stockholders’ Equity Retained earnings 1,345,851 1,343,268 2,583 In January 2016, the FASB issued ASU 2016-01, which provides guidance on the classification and measurement of financial assets and liabilities (equity securities and financial liabilities) under the fair value option and the presentation and disclosure requirements for financial instruments. In February 2018, ASU 2018-03 was issued to clarify certain aspects of the guidance issued in January 2016. The guidance modifies how entities measure equity investments and present changes in the fair value of financial liabilities. Under the new guidance, entities measure equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any related changes in fair value in net income unless the investments qualify for the new practicality exception. A measurement alternative exists for those equity investments that do not have a readily determinable fair value. These investments may be measured at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The standard also includes a new impairment model for equity investments without readily determinable fair values. The new model is a single-step model under which the Company is required to perform a qualitative assessment each reporting period to identify impairment. When a qualitative assessment indicates that an impairment exists, the Company will estimate the fair value of the investment and recognize in current earnings an impairment loss equal to the difference between the fair value and the carrying amount of the equity investment. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018. In February 2016, the FASB issued ASU 2016-02 and subsequent amendments, which requires organizations to recognize leases on the balance sheet, and disclose key information about leasing arrangements. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to recognize an ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and recognition of expense in the income statement. The new standard is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. We expect to adopt the new standard on its effective date. A modified retrospective transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. We expect to adopt the new standard on January 1, 2019 and use the effective date (option 1) as our date of initial application. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. The new standard provides a number of optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. The new standard also provides practical expedients for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets in transition. While we continue to assess all of the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our operating leases and the significant new disclosures about our leasing activities. In August 2016, the FASB issued ASU 2016-15, which provides guidance on the classification of certain cash receipts and cash payments within the statement of cash flows. This guidance provides clarification for the following types of transactions: debt prepayment or extinguishment costs, settlement of zero-coupon debt instruments or other debt instruments with coupon rates that are insignificant in relation to the effective interest rate of the borrowing, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, proceeds from the settlement of corporate-owned life insurance, distributions received from equity method investees and beneficial interest in securitization transactions. The guidance also clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. However, early adoption was permitted and an entity that elects early adoption must adopt all of the amendments on a retrospective basis in the period of adoption. The Company adopted this standard in the fourth quarter of 2017. In November 2016, the FASB issued ASU 2016-18, which provides guidance to address the diversity in the classification and presentation of changes in restricted cash on the statement of cash flows. The amendments in this standard require that a statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018 and appropriate disclosures are included on the statement of cash flows to the extent applicable. In January 2017, the FASB issued ASU 2017-01, which provides guidance to clarify the definition of a business to assist entities in evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments in this standard provide a screen to determine when an integrated set of assets and activities (collectively referred to as a “set”) is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. If the screen is not met, the amendments in this update (1) require that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) remove the evaluation of whether a market participant could replace missing elements. The amendments also narrow the definition of the term “output” so that the term is consistent with how outputs are described in the new guidance for revenue recognition. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018. In March 2017, the FASB issued ASU 2017-07, which provides guidance to disaggregate the current service cost component from the other components of net periodic benefit costs. The service cost component should be presented within compensation costs while the other components should be presented outside of income from operations. The guidance also clarifies that only the service cost component is eligible for capitalization. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018 and the prior periods were restated as follows: Original Revised Balance Adjustment Balance Revised Condensed Consolidated Statements of Income Three Months Ended September 30, 2017 Cost of sales (exclusive of depreciation and amortization) $ 408,081 $ (300) $ 407,781 Selling, research & development and administrative 95,748 (212) 95,536 Total Operating Expenses 543,916 (512) 543,404 Operating Income 80,410 512 80,922 Miscellaneous, net (2,200) (512) (2,712) Total Other (Expense) Income (10,892) (512) (11,404) Income before Income Taxes 69,518 — 69,518 Nine Months Ended September 30, 2017 Cost of sales (exclusive of depreciation and amortization) $ 1,192,967 $ (838) $ 1,192,129 Selling, research & development and administrative 292,923 (649) 292,274 Total Operating Expenses 1,600,550 (1,487) 1,599,063 Operating Income 242,838 1,487 244,325 Miscellaneous, net (509) (1,487) (1,996) Total Other (Expense) Income (24,272) (1,487) (25,759) Income before Income Taxes 218,566 — 218,566 In May 2017, the FASB issued ASU 2017-09, which provides clarification on applying the standards for stock compensation accounting. The new standard provides guidance on which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017. The Company adopted the requirements of this standard during the first quarter of 2018. In August 2017, the FASB issued ASU 2017-12, which provides new guidance to improve the accounting for hedging activities. The guidance changes the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition, the guidance makes certain targeted improvements to simplify the application of the hedge accounting guidance in current U.S. GAAP. The new standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. However, early application is permitted in any interim period after the issuance of this guidance. The Company adopted this standard in the third quarter of 2017. See details in Note 9 – Derivative Instruments and Hedging Activities. Other accounting standards that have been issued by the FASB or other standards-setting bodies did not have a material impact on our Condensed Consolidated Financial Statements.
RETIREMENT OF COMMON STOCK	RETIREMENT OF COMMON STOCK During the first nine months of 2018, the Company repurchased 668 thousand shares of common stock, of which 623 thousand shares were immediately retired. During the first nine months of 2017, the Company repurchased 1.4 million shares of common stock, of which 512 thousand shares were immediately retired. Common stock was reduced by the number of shares retired at $0.01 par value per share. The Company allocates the excess purchase price over par value between additional paid-in capital and retained earnings.
INCOME TAXES	INCOME TAXES The Company computes taxes on income in accordance with the tax rules and regulations of the many taxing authorities where income is earned. The income tax rates imposed by these taxing authorities may vary substantially. Taxable income may differ from pre-tax income for financial accounting purposes. To the extent that these differences create temporary differences between the tax basis of an asset or liability and our reported amount in the financial statements, an appropriate provision for deferred income taxes is made. The Tax Cuts and Jobs Act (the “TCJA”) was enacted in the United States on December 22, 2017. The TCJA lowered the corporate tax rate from 35.0% to 21.0% and imposed a one-time transition tax on unremitted earnings as of the end of 2017, and featured many other tax law provisions. New provisions for 2018 include, most notably, a tax on global intangible low-taxed income (“GILTI”) and the base erosion anti-abuse tax (“BEAT”), repeal of the domestic manufacturing deduction and limitations on the deductibility of executive compensation. The SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the U.S. GAAP application of the TCJA. SAB 118 provides us up to a year to finalize accounting for the impacts of the TCJA. The Company estimated provisional tax amounts related to the transition tax and components of the revaluation of deferred tax assets and liabilities for the period ended December 31, 2017. This resulted in the recognition of a net tax charge of approximately $24.8 million, comprised of a provisional charge of $31.6 million for the transition tax and a provisional benefit of $6.8 million related to the corporate rate change. While our accounting for the enactment of the new U.S. tax legislation is not complete, during the three months ended September 30, 2018, we recognized a provisional, discrete $1.9 million net tax benefit, consisting of a provisional $2.8 million benefit related to the change in the corporate tax rate that was partially offset by a provisional $0.9 million charge for the transition tax liability. During the nine months ended September 30, 2018, we recognized $5.4 million in provisional, discrete net tax benefits, composed of the $2.8 million benefit for the change in corporate tax rate and a net $2.6 million decrease to our transition tax liability. The benefit for the lower transition tax liability reflects additional guidance issued by the U.S. Treasury during 2018. The Company expects both provisional amounts to be finalized in the fourth quarter of 2018 when the 2017 U.S. tax return filings are completed. The Company has elected to account for the tax on GILTI as a period cost and not as a measure of deferred taxes in the current period. All of the Company’s non-U.S. earnings are subject to U.S. taxation, either from the TCJA transition tax on accumulated non-U.S. earnings as of the end of 2017 or the GILTI provisions on non-U.S. earnings going forward. The Company maintains its assertion that the cash and distributable reserves at its non-U.S. affiliates are indefinitely reinvested. The Company will provide for the necessary withholding and local income taxes when management decides that an affiliate should make a distribution. These decisions are made taking into consideration the financial requirements of the non-U.S. affiliates and the global cash management goals of the Company. The Company provides a liability for the amount of unrecognized tax benefits from uncertain tax positions. This liability is provided whenever the Company determines that a tax benefit will not meet a more-likely-than-not threshold for recognition. See Note 5 - Income Taxes for more information.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2018
Accounting Standards Update 2014-09 | Restatement of beginning balances
Summary of impacts of adoption of recent accounting pronouncements	Balance at Balance at December 31, 2017 Adjustment January 1, 2018 Consolidated Balance Sheets Assets Inventories $ 337,216 $ (14,637) $ 322,579 Prepaid and other 109,791 13,984 123,775 Liabilities Accounts payable and accrued liabilities 461,579 (5,706) 455,873 Deferred income taxes 20,995 1,292 22,287 Deferred and other non-current liabilities 5,608 824 6,432 Stockholders’ Equity Retained earnings 1,301,147 2,937 1,304,084
Accounting Standards Update 2014-09 | Cumulative effect of change
Summary of impacts of adoption of recent accounting pronouncements	For the Three Months Ended September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 341,760 $ 340,787 $ 973 Pharma 227,515 227,526 (11) Food + Beverage 96,500 96,478 22 Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 435,379 434,601 778 Provision for income taxes 11,920 11,866 54 Net income 39,022 38,870 152 For the Nine Months Ended September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Statements of Income Net Sales Beauty + Home $ 1,088,469 $ 1,087,922 $ 547 Pharma 698,851 699,299 (448) Food + Beverage 292,413 292,437 (24) Costs and Expenses Cost of sales (exclusive of depreciation and amortization) 1,355,445 1,354,844 601 Provision for income taxes 52,966 53,138 (172) Net income 154,091 154,445 (354) September 30, 2018 Balances Without Effect of As Adoption of Change Reported ASC 606 Higher/(Lower) Consolidated Balance Sheets Assets Inventories $ 394,264 $ 409,502 $ (15,238) Prepaid and other 118,613 102,767 15,846 Liabilities Accounts payable and accrued liabilities 524,528 528,081 (3,553) Deferred income taxes 48,857 47,737 1,120 Deferred and other non-current liabilities 24,837 24,379 458 Stockholders’ Equity Retained earnings 1,345,851 1,343,268 2,583
Accounting Standards Update 2017-07
Summary of impacts of adoption of recent accounting pronouncements	Original Revised Balance Adjustment Balance Revised Condensed Consolidated Statements of Income Three Months Ended September 30, 2017 Cost of sales (exclusive of depreciation and amortization) $ 408,081 $ (300) $ 407,781 Selling, research & development and administrative 95,748 (212) 95,536 Total Operating Expenses 543,916 (512) 543,404 Operating Income 80,410 512 80,922 Miscellaneous, net (2,200) (512) (2,712) Total Other (Expense) Income (10,892) (512) (11,404) Income before Income Taxes 69,518 — 69,518 Nine Months Ended September 30, 2017 Cost of sales (exclusive of depreciation and amortization) $ 1,192,967 $ (838) $ 1,192,129 Selling, research & development and administrative 292,923 (649) 292,274 Total Operating Expenses 1,600,550 (1,487) 1,599,063 Operating Income 242,838 1,487 244,325 Miscellaneous, net (509) (1,487) (1,996) Total Other (Expense) Income (24,272) (1,487) (25,759) Income before Income Taxes 218,566 — 218,566

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Sep. 30, 2018
REVENUE.
Schedule of revenue by segment by geographic area	For the Three Months Ended September 30, 2018 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 190,267 $ 83,353 $ 44,653 $ 23,487 $ 341,760 Pharma 161,733 50,126 6,165 9,491 227,515 Food + Beverage 29,472 47,870 7,476 11,682 96,500 Total $ 381,472 $ 181,349 $ 58,294 $ 44,660 $ 665,775 For the Nine Months Ended September 30, 2018 Latin Segment Europe Domestic America Asia Total Beauty + Home $ 622,184 $ 252,709 $ 140,238 $ 73,338 $ 1,088,469 Pharma 520,574 132,496 19,229 26,552 698,851 Food + Beverage 90,185 143,005 23,343 35,880 292,413 Total $ 1,232,943 $ 528,210 $ 182,810 $ 135,770 $ 2,079,733
Schedule of opening and closing balances of contract assets and contract liabilities	Balance as of Balance as of January 1, 2018 September 30, 2018 Increase/ (opening) (closing) (Decrease) Contract asset (current) $ 13,984 $ 15,846 $ 1,862 Contract asset (long-term) $ — $ — $ — Contract liability (current) $ 15 $ 413 $ 398 Contract liability (long-term) $ 824 $ 458 $ (366)

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2018
INVENTORIES
Schedule of inventories, by component	September 30, December 31, Raw materials $ 111,985 $ 99,196 Work in process 127,569 107,307 Finished goods 154,710 130,713 Total $ 394,264 $ 337,216

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2018
GOODWILL AND OTHER INTANGIBLE ASSETS
Schedule of changes in the carrying amount of goodwill	Beauty + Food + Corporate Home Pharma Beverage & Other Total Goodwill $ 223,947 $ 203,069 $ 16,871 $ 1,615 $ 445,502 Accumulated impairment losses — — — (1,615) (1,615) Balance as of December 31, 2017 $ 223,947 $ 203,069 $ 16,871 $ — $ 443,887 Acquisition 5,565 154,827 106,389 — 266,781 Foreign currency exchange effects (4,853) (6,237) (248) — (11,338) Goodwill $ 224,659 $ 351,659 $ 123,012 $ 1,615 $ 700,945 Accumulated impairment losses — — — (1,615) (1,615) Balance as of September 30, 2018 $ 224,659 $ 351,659 $ 123,012 $ — $ 699,330
Summary of amortized intangible assets	September 30, 2018 December 31, 2017 Weighted Average Gross Gross Amortization Period Carrying Accumulated Net Carrying Accumulated Net (Years) Amount Amortization Value Amount Amortization Value Amortized intangible assets: Patents 0.3 $ 7,645 $ (7,535) $ 110 $ 7,819 $ (7,806) $ 13 Acquired technology 13.5 93,171 (16,786) 76,385 47,571 (14,624) 32,947 Customer relationships 14.6 199,591 (18,162) 181,429 68,886 (13,401) 55,485 Trademarks and trade names 7.0 21,333 (5,311) 16,022 6,965 (4,485) 2,480 License agreements and other 9.3 19,808 (10,644) 9,164 14,862 (10,327) 4,535 Total intangible assets 13.2 $ 341,548 $ (58,438) $ 283,110 $ 146,103 $ (50,643) $ 95,460
Schedule of future estimated amortization expense	Future estimated amortization expense for the years ending December 31 is as follows: 2018 $ 6,023 (remaining estimated amortization for 2018) 2019 23,888 2020 22,786 2021 22,407 2022 and thereafter 208,006

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Sep. 30, 2018
DEBT
Schedule of long-term obligations	At September 30, 2018, the Company’s long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.00% – 18.00%, due in monthly and annual installments through 2025 $ 17,521 $ — $ 17,521 Senior unsecured notes 3.2%, due in 2022 75,000 94 74,906 Senior unsecured debts 3.6% floating, equal annual installments through 2022 224,000 578 223,422 Senior unsecured notes 3.5%, due in 2023 125,000 190 124,810 Senior unsecured notes 1.0%, due in 2023 116,095 456 115,639 Senior unsecured notes 3.4%, due in 2024 50,000 80 49,920 Senior unsecured notes 3.5%, due in 2024 100,000 190 99,810 Senior unsecured notes 1.2%, due in 2024 232,190 944 231,246 Senior unsecured notes 3.6%, due in 2025 125,000 215 124,785 Senior unsecured notes 3.6%, due in 2026 125,000 215 124,785 Capital lease obligations 8,932 — 8,932 $ 1,198,738 $ 2,962 $ 1,195,776 Current maturities of long-term obligations (64,039) — (64,039) Total long-term obligations $ 1,134,699 $ 2,962 $ 1,131,737 At December 31, 2017, the Company’s long-term obligations consisted of the following: Unamortized Debt Issuance Principal Costs Net Notes payable 0.61% – 18.00%, due in monthly and annual installments through 2025 $ 15,349 $ — $ 15,349 Senior unsecured notes 3.2%, due in 2022 75,000 113 74,887 Senior unsecured debts 2.6% floating, equal annual installments through 2022 280,000 692 279,308 Senior unsecured notes 3.5%, due in 2023 125,000 217 124,783 Senior unsecured notes 1.0%, due in 2023 120,095 526 119,569 Senior unsecured notes 3.4%, due in 2024 50,000 89 49,911 Senior unsecured notes 3.5%, due in 2024 100,000 217 99,783 Senior unsecured notes 1.2%, due in 2024 240,190 1,066 239,124 Senior unsecured notes 3.6%, due in 2025 125,000 238 124,762 Senior unsecured notes 3.6%, due in 2026 125,000 238 124,762 Capital lease obligations 741 — 741 $ 1,256,375 $ 3,396 $ 1,252,979 Current maturities of long-term obligations (61,833) — (61,833) Total long-term obligations $ 1,194,542 $ 3,396 $ 1,191,146
Schedule of covenants on revolving credit facility and corporate long-term obligations	Requirement Level at September 30, 2018 Consolidated Leverage Ratio (1) Maximum of 3.50 to 1.00 2.05 to 1.00 Consolidated Interest Coverage Ratio (1) Minimum of 3.00 to 1.00 12.36 to 1.00 (1) Definitions of ratios are included as part of the revolving credit facility agreement and the private placement agreements.
Schedule of borrowing arrangements through wholly owned UK subsidiary	Debt Type Amount Term/Maturity Interest Rate Bank term loan $ 280,000 5 year amortizing/July 2022 2.56% floating swapped to 1.36% fixed Bank revolver € 150,000 5 year/July 2022 1.10% floating Private placement € 100,000 6 year/July 2023 0.98% fixed Private placement € 200,000 7 year/July 2024 1.17% fixed

RETIREMENT AND DEFERRED COMPE_2

RETIREMENT AND DEFERRED COMPENSATION PLANS (Tables)	9 Months Ended
	Sep. 30, 2018
RETIREMENT AND DEFERRED COMPENSATION PLANS
Components of net periodic benefit cost	Domestic Plans Foreign Plans Three Months Ended September 30, Service cost $ 2,853 $ 2,426 $ 1,457 $ 1,447 Interest cost 1,713 1,752 445 459 Expected return on plan assets (2,803) (2,470) (645) (627) Amortization of net loss 1,214 801 422 493 Amortization of prior service cost — — 122 104 Net periodic benefit cost $ 2,977 $ 2,509 $ 1,801 $ 1,876 Domestic Plans Foreign Plans Nine Months Ended September 30, Service cost $ $ 7,279 $ 4,479 $ 4,166 Interest cost 5,257 1,374 1,321 Expected return on plan assets (7,409) (1,982) (1,781) Amortization of net loss 2,403 1,301 1,400 Amortization of prior service cost — — 376 296 Net periodic benefit cost $ 8,918 $ 7,530 $ 5,548 $ 5,402

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)	9 Months Ended
	Sep. 30, 2018
ACCUMULATED OTHER COMPREHENSIVE INCOME
Changes in Accumulated Other Comprehensive Income/(Loss) by Component	Foreign Defined Benefit Currency Pension Plans Derivatives Total Balance - December 31, 2016 $ (259,888) $ (59,775) $ (46) $ (319,709) Other comprehensive income (loss) before reclassifications 69,493 — (9,237) 60,256 Amounts reclassified from accumulated other comprehensive income — 2,699 5,667 8,366 Net current-period other comprehensive income 69,493 2,699 (3,570) 68,622 Balance - September 30, 2017 $ (190,395) $ (57,076) $ (3,616) $ (251,087) Balance - December 31, 2017 $ (185,503) $ (64,595) $ (3,204) $ (253,302) Other comprehensive income (loss) before reclassifications (53,141) — 12,507 (40,634) Amounts reclassified from accumulated other comprehensive income — 4,032 (11,444) (7,412) Net current-period other comprehensive income (53,141) 4,032 1,063 (48,046) Balance - September 30, 2018 $ (238,644) $ (60,563) $ (2,141) $ (301,348)
Reclassifications Out of Accumulated Other Comprehensive (Loss) Income	Reclassifications Out of Accumulated Other Comprehensive (Loss) Income: Amount Reclassified from Details about Accumulated Other Accumulated Other Affected Line in the Statement Comprehensive Income Components Comprehensive Income Where Net Income is Presented Three Months Ended September 30, Defined Benefit Pension Plans Amortization of net loss $ 1,636 $ 1,294 (1) Amortization of prior service cost 122 104 (1) 1,758 1,398 Total before tax (425) (474) Tax benefit $ 1,333 $ 924 Net of tax Derivatives Changes in treasury locks $ 4 $ 11 Interest Expense Changes in cross currency swap: interest component (1,337) (678) Interest Expense Changes in cross currency swap: foreign exchange component (2,131) 7,481 Miscellaneous, net (3,464) 6,814 Total before tax 588 (1,161) Tax benefit $ (2,876) $ 5,653 Net of tax Total reclassifications for the period $ (1,543) $ 6,577 Amount Reclassified from Details about Accumulated Other Accumulated Other Affected Line in the Statement Comprehensive Income Components Comprehensive Income Where Net Income is Presented Nine Months Ended September 30, Defined Benefit Pension Plans Amortization of net loss $ 4,943 $ 3,803 (1) Amortization of prior service cost 376 296 (1) 5,319 4,099 Total before tax (1,287) (1,400) Tax benefit $ 4,032 $ 2,699 Net of tax Derivatives Changes in treasury locks $ 26 $ 32 Interest Expense Changes in cross currency swap: interest component (3,824) (678) Interest Expense Changes in cross currency swap: foreign exchange component (9,984) 7,481 Miscellaneous, net (13,782) 6,835 Total before tax 2,338 (1,168) Tax benefit $ (11,444) $ 5,667 Net of tax Total reclassifications for the period $ (7,412) $ 8,366 (1) These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 7 – Retirement and Deferred Compensation Plans for additional details).

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	9 Months Ended
	Sep. 30, 2018
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Schedule of Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets	Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets as of September 30, 2018 and December 31, 2017 September 30, 2018 December 31, 2017 Derivatives Derivatives Derivatives not Derivatives not Designated Designated Designated Designated Balance Sheet as Hedging as Hedging as Hedging as Hedging Location Instruments Instruments Instruments Instruments Derivative Assets Foreign Exchange Contracts Prepaid and other $ — $ 262 $ — $ 663 $ — $ 262 $ — $ 663 Derivative Liabilities Foreign Exchange Contracts Accounts payable and accrued liabilities $ — $ 881 $ — $ 1,604 Cross Currency Swap Contract (1) Accounts payable and accrued liabilities 4,712 — 16,309 — $ 4,712 $ 881 $ 16,309 $ 1,604 (1) This cross currency swap contract is composed of both an interest component and a foreign exchange component.
Schedule of Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)	The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Quarters Ended September 30, 2018 and 2017 Amount of Gain (Loss) Total Amount Amount of Gain (Loss) Location of (Loss) Reclassified from of Affected Derivatives in Cash Recognized in Gain Recognized Accumulated Income Flow Hedging Other Comprehensive in Income on Other Comprehensive Statement Relationships Income on Derivative Derivatives Income on Derivative Line Item Cross currency swap contract: Interest component $ (68) $ (3,648) Interest expense $ 1,337 $ 678 $ (8,735) Foreign exchange component 2,131 (7,481) Miscellaneous, net 2,131 (7,481) (2,928) $ 2,063 $ (11,129) $ 3,468 $ (6,803) $ (11,663) The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) for the Nine Months Ended September 30, 2018 and 2017 Amount of Gain (Loss) Total Amount Amount of Gain (Loss) Location of (Loss) Reclassified from of Affected Derivatives in Cash Recognized in Gain Recognized Accumulated Income Flow Hedging Other Comprehensive in Income on Other Comprehensive Statement Relationships Income on Derivative Derivatives Income on Derivative Line Item Cross currency swap contract: Interest component $ 5,084 $ (3,648) Interest expense $ 3,824 $ 678 $ (24,754) Foreign exchange component 9,984 (7,481) Miscellaneous, net 9,984 (7,481) (4,372) $ 15,068 $ (11,129) $ 13,808 $ (6,803) $ (29,126)
Schedule of Effect of Derivatives Not Designated as Hedging Instruments on the Condensed Consolidated Statements of Income	The Effect of Derivatives Not Designated as Hedging Instruments on the Condensed Consolidated Statements of Income for the Quarters Ended September 30, 2018 and 2017 Amount of (Loss) Gain Derivatives Not Designated Location of (Loss) Gain Recognized Recognized in Income as Hedging Instruments in Income on Derivatives on Derivatives Foreign Exchange Contracts Other (Expense) Income: $ (1,011) $ (15,534) $ (1,011) $ (15,534) The Effect of Derivatives Not Designated as Hedging Instruments on the Condensed Consolidated Statements of Income for the Nine Months Ended September 30, 2018 and 2017 Amount of (Loss) Gain Derivatives Not Designated Location of (Loss) Gain Recognized Recognized in Income as Hedging Instruments in Income on Derivatives on Derivatives Foreign Exchange Contracts Other (Expense) Income: $ 102 $ (64,651) $ 102 $ (64,651)
Schedule of offsetting derivative assets and liabilities	Gross Amounts not Offset Gross Amounts Net Amounts in the Statement of Offset in the Presented in Financial Position Gross Statement of the Statement of Financial Cash Collateral Net Amount Financial Position Financial Position Instruments Received Amount Description September 30, 2018 Derivative Assets $ 262 — $ 262 — — $ 262 Total Assets $ 262 — $ 262 — — $ 262 Derivative Liabilities $ 5,593 — $ 5,593 — — $ 5,593 Total Liabilities $ 5,593 — $ 5,593 — — $ 5,593 December 31, 2017 Derivative Assets $ 663 — $ 663 — — $ 663 Total Assets $ 663 — $ 663 — — $ 663 Derivative Liabilities $ 17,913 — $ 17,913 — — $ 17,913 Total Liabilities $ 17,913 — $ 17,913 — — $ 17,913

FAIR VALUE (Tables)

FAIR VALUE (Tables)	9 Months Ended
	Sep. 30, 2018
FAIR VALUE
Schedule of fair values of financial assets and liabilities	As of September 30, 2018, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 262 $ — $ 262 $ — Total assets at fair value $ 262 $ — $ 262 $ — Liabilities Foreign exchange contracts (1) $ 881 $ — $ 881 $ — Cross currency swap contract (1) 4,712 — 4,712 — Total liabilities at fair value $ 5,593 $ — $ 5,593 $ — As of December 31, 2017, the fair values of our financial assets and liabilities were categorized as follows: Total Level 1 Level 2 Level 3 Assets Foreign exchange contracts (1) $ 663 $ — $ 663 $ — Total assets at fair value $ 663 $ — $ 663 $ — Liabilities Foreign exchange contracts (1) $ 1,604 $ — $ 1,604 $ — Cross currency swap contract (1) 16,309 — 16,309 — Total liabilities at fair value $ 17,913 $ — $ 17,913 $ — (1) Market approach valuation technique based on observable market transactions of spot and forward rates.

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2018
STOCK-BASED COMPENSATION
Weighted-average assumptions used to estimate fair value of stock options granted	Stock Awards Plans: Nine Months Ended September 30, Dividend Yield 1.5 % 1.7 % Expected Stock Price Volatility 14.2 % 15.8 % Risk-free Interest Rate 2.8 % 2.2 % Expected Life of Option (years) 6.6 6.7
Summary of option activity	Stock Awards Plans Director Stock Option Plans Weighted Average Weighted Average Options Exercise Price Options Exercise Price Outstanding, January 1, 2018 8,059,319 $ 61.67 214,967 $ 57.44 Granted 603,901 88.39 — — Exercised (1,439,333) 52.69 (57,767) 55.71 Forfeited or expired (243,110) 74.32 — — Outstanding at September 30, 2018 6,980,777 $ 65.39 157,200 $ 58.08 Exercisable at September 30, 2018 5,114,822 $ 60.65 157,200 $ 58.08 Weighted-Average Remaining Contractual Term (Years): Outstanding at September 30, 2018 6.0 4.3 Exercisable at September 30, 2018 5.2 4.3 Aggregate Intrinsic Value: Outstanding at September 30, 2018 $ 295,630 $ 7,807 Exercisable at September 30, 2018 $ 240,839 $ 7,807 Intrinsic Value of Options Exercised During the Nine Months Ended: September 30, 2018 $ 62,895 $ 2,187 September 30, 2017 $ 44,734 $ 1,995
Weighted-average assumptions used to estimate fair value of restricted stock units	Nine Months Ended September 30, Fair value per stock award $ 128.70 Measurement date stock price $ 89.42 Assumptions: Aptar's stock price expected volatility 12.30 % Expected average volatility of peer companies 27.50 % Correlation assumption 20.20 % Risk-free interest rate 2.42 % Dividend yield assumption 1.43 %
Summary of restricted stock unit activity	Time-Based RSUs Performance-Based RSUs Weighted Average Weighted Average Units Grant-Date Fair Value Units Grant-Date Fair Value Nonvested at January 1, 2018 124,067 $ 74.65 — $ — Granted 187,502 96.26 80,843 111.55 Vested (33,882) 75.57 — — Forfeited (31,672) 78.62 (9,762) 111.55 Nonvested at September 30, 2018 246,015 $ 90.48 71,081 $ 111.55

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2018
EARNINGS PER SHARE
Reconciliation of Basic and Diluted Earnings Per Share	Three Months Ended September 30, 2018 September 30, 2017 Diluted Basic Diluted Basic Consolidated operations Income available to common stockholders $ 38,996 $ 38,996 $ 53,523 $ 53,523 Average equivalent shares Shares of common stock 62,378 62,378 62,592 62,592 Effect of dilutive stock based compensation Stock options 2,659 — 2,171 — Restricted stock 92 — 58 — Total average equivalent shares 65,129 62,378 64,821 62,592 Net income per share $ 0.60 $ 0.63 $ 0.83 $ 0.86 Nine Months Ended September 30, 2018 September 30, 2017 Diluted Basic Diluted Basic Consolidated operations Income available to common stockholders $ 154,071 $ 154,071 $ 170,517 $ 170,517 Average equivalent shares Shares of common stock 62,304 62,304 62,527 62,527 Effect of dilutive stock-based compensation Stock options 2,440 — 2,046 — Restricted stock 78 — 53 — Total average equivalent shares 64,822 62,304 64,626 62,527 Net income per share $ 2.38 $ 2.47 $ 2.64 $ 2.73

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2018
SEGMENT INFORMATION
Financial information regarding the Company's reportable segments	Three Months Ended September 30, Nine Months Ended September 30, Total Sales: Beauty + Home $ 346,040 $ 338,068 $ 1,103,664 $ 992,476 Pharma 227,691 199,551 699,105 598,168 Food + Beverage 97,297 91,852 294,362 269,159 Total Sales 671,028 629,471 2,097,131 1,859,803 Less: Intersegment Sales: Beauty + Home $ 4,280 $ 4,320 $ 15,195 $ 14,163 Pharma 176 4 254 7 Food + Beverage 797 821 1,949 2,245 Total Intersegment Sales $ 5,253 $ 5,145 $ 17,398 $ 16,415 Net Sales: Beauty + Home $ 341,760 $ 333,748 $ 1,088,469 $ 978,313 Pharma 227,515 199,547 698,851 598,161 Food + Beverage 96,500 91,031 292,413 266,914 Net Sales $ 665,775 $ 624,326 $ 2,079,733 $ 1,843,388 Adjusted EBITDA (1): Beauty + Home $ 42,174 $ 42,627 $ 141,155 $ 129,265 Pharma 84,516 66,260 250,709 204,750 Food + Beverage 15,482 18,116 46,284 49,756 Corporate & Other, unallocated (7,954) (8,778) (28,576) (26,924) Acquisition-related costs (2) (10,369) — (12,932) — Restructuring Initiatives (3) (23,852) — (48,002) — Depreciation and amortization (41,857) (40,087) (123,133) (114,660) Interest Expense (8,735) (9,733) (24,754) (25,707) Interest Income 1,537 1,113 6,306 2,086 Income before Income Taxes $ 50,942 $ 69,518 $ 207,057 $ 218,566 (1) The Company evaluates performance of our business units and allocates resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring and acquisition-related costs. (2) Acquisition-related costs include transaction costs and purchase accounting adjustments related to inventory for acquisitions (see Note 17 – Acquisitions for further details). (3) Restructuring Initiatives includes expense items for the three and nine months ended September 30, 2018 as follows (see Note 18 – Restructuring Initiatives for further details):
Restructuring Initiatives	Three Months Ended September 30, Nine Months Ended September 30, Restructuring Initiatives by Segment Beauty + Home $ 18,854 $ — $ 38,501 $ — Pharma 2,008 — 3,596 — Food + Beverage 2,638 — 4,307 — Corporate & Other 352 — 1,598 — Total Restructuring Initiatives $ 23,852 $ — $ 48,002 $ —

ACQUISITIONS (Tables)

ACQUISITIONS (Tables) - CSP Technologies Member	9 Months Ended
	Sep. 30, 2018
Acquisitions
Summary of assets acquired and liabilities assumed at estimated fair value	August 27, 2018 Assets Cash and equivalents $ 24,053 Accounts receivable 21,250 Inventories 45,500 Prepaid and other 2,925 Property, plant and equipment 101,579 Goodwill 261,216 Intangible assets 198,200 Other miscellaneous assets 980 Liabilities Current maturities of long-term obligations 129 Accounts payable and accrued liabilities 30,871 Long-term obligations 6,037 Deferred income taxes 47,504 Retirement and deferred compensation plans 212 Deferred and other non-current liabilities 17,492 Net assets acquired $ 553,458
Summary of the fair value estimates of the acquired identifiable intangible assets and weighted-average useful lives as of the acquisition date	Weighted-Average Estimated Useful Life Fair Value (in years) of Asset Acquired technology $ 46,700 Customer relationships 132,300 Trademarks and trade names 14,600 License agreements and other 4,600 Total $ 198,200
Schedule of unaudited pro forma financial information	Three Months Ended September 30, Nine Months Ended September 30, Net Sales $ 687,201 $ 659,741 $ 2,172,737 $ 1,943,297 Net Income Attributable to AptarGroup Inc. 48,034 57,829 158,527 168,028 Net Income per common share — basic 0.77 0.92 2.54 2.69 Net Income per common share — diluted 0.74 0.89 2.45 2.60

RESTRUCTURING INITIATIVES (Tabl

RESTRUCTURING INITIATIVES (Tables)	9 Months Ended
	Sep. 30, 2018
RESTRUCTURING INITIATIVES.
Activity associated with the entity's restructuring initiatives	Beginning Net Charges for Ending Reserve at the Nine Months Reserve at 12/31/2017 Ended 9/30/2018 Cash Paid FX Impact 9/30/2018 Employee severance $ 2,258 $ 2,035 $ (2,414) $ (52) $ 1,827 Professional fees and other costs — 45,967 (35,033) 637 11,571 Totals $ 2,258 $ 48,002 $ (37,447) $ 585 $ 13,398

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basis of Presentation (Details) - Argentina - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Amount Recognized in Income Due to Inflationary Accounting	$ (1)
Maximum | Consolidated net revenues | Geographic concentration risk
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk percentage		2.00%

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – Revenue Recognition, Adjustments to Opening Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jan. 01, 2018	Dec. 31, 2017
Assets
Inventories	$ 394,264	$ 322,579	$ 337,216
Prepaid and other	118,613	123,775	109,791
Liabilities
Accounts payable and accrued liabilities	524,528	455,873	461,579
Deferred income taxes	48,857	22,287	20,995
Deferred and other non-current liabilities	24,837	6,432	5,608
Stockholders' Equity
Retained earnings	1,345,851	1,304,084	$ 1,301,147
Adjustment/Effect of Change | Accounting Standards Update 2014-09
Assets
Inventories	(15,238)	(14,637)
Prepaid and other	15,846	13,984
Liabilities
Accounts payable and accrued liabilities	(3,553)	(5,706)
Deferred income taxes	1,120	1,292
Deferred and other non-current liabilities	458	824
Stockholders' Equity
Retained earnings	$ 2,583	$ 2,937

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – Revenue Recognition, Balances Reported with and without Adoption of ASC 606 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Jan. 01, 2018	Dec. 31, 2017
Consolidated Statements of Income
Net sales	$ 665,775	$ 624,326	$ 2,079,733	$ 1,843,388
Costs and Expenses
Cost of sales	435,379	407,781	1,355,445	1,192,129
Provision for income taxes	11,920	15,989	52,966	48,043
Net income	39,022	53,529	154,091	170,523
Assets
Accounts and note receivable	580,450		580,450			$ 510,426
Inventories	394,264		394,264		$ 322,579	337,216
Prepaid and other	118,613		118,613		123,775	109,791
Liabilities
Accounts payable and accrued liabilities	524,528		524,528		455,873	461,579
Deferred income taxes	48,857		48,857		22,287	20,995
Deferred and other non-current liabilities	24,837		24,837		6,432	5,608
Stockholders' Equity
Retained earnings	1,345,851		1,345,851		1,304,084	$ 1,301,147
Beauty + Home
Consolidated Statements of Income
Net sales	341,760	333,748	1,088,469	978,313
Pharma
Consolidated Statements of Income
Net sales	227,515	199,547	698,851	598,161
Food + Beverage
Consolidated Statements of Income
Net sales	96,500	$ 91,031	292,413	$ 266,914
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09
Costs and Expenses
Cost of sales	434,601		1,354,844
Provision for income taxes	11,866		53,138
Net income	38,870		154,445
Assets
Inventories	409,502		409,502
Prepaid and other	102,767		102,767
Liabilities
Accounts payable and accrued liabilities	528,081		528,081
Deferred income taxes	47,737		47,737
Deferred and other non-current liabilities	24,379		24,379
Stockholders' Equity
Retained earnings	1,343,268		1,343,268
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Beauty + Home
Consolidated Statements of Income
Net sales	340,787		1,087,922
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Pharma
Consolidated Statements of Income
Net sales	227,526		699,299
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Food + Beverage
Consolidated Statements of Income
Net sales	96,478		292,437
Adjustment/Effect of Change | Accounting Standards Update 2014-09
Costs and Expenses
Cost of sales	778		601
Provision for income taxes	54		(172)
Net income	152		(354)
Assets
Inventories	(15,238)		(15,238)		(14,637)
Prepaid and other	15,846		15,846		13,984
Liabilities
Accounts payable and accrued liabilities	(3,553)		(3,553)		(5,706)
Deferred income taxes	1,120		1,120		1,292
Deferred and other non-current liabilities	458		458		824
Stockholders' Equity
Retained earnings	2,583		2,583		$ 2,937
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Beauty + Home
Consolidated Statements of Income
Net sales	973		547
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Pharma
Consolidated Statements of Income
Net sales	(11)		(448)
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Food + Beverage
Consolidated Statements of Income
Net sales	$ 22		$ (24)

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – Adoption of ASU 2017-07 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of sales	$ 435,379	$ 407,781	$ 1,355,445	$ 1,192,129
Selling, research & development and administrative	103,574	95,536	323,146	292,274
Total Operating Expenses	604,662	543,404	1,849,726	1,599,063
Operating Income	61,113	80,922	230,007	244,325
Miscellaneous, net	(2,928)	(2,712)	(4,372)	(1,996)
Total Other (Expense) Income	(10,171)	(11,404)	(22,950)	(25,759)
Income before Income Taxes	$ 50,942	69,518	$ 207,057	218,566
Original Balance | Accounting Standards Update 2017-07
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of sales		408,081		1,192,967
Selling, research & development and administrative		95,748		292,923
Total Operating Expenses		543,916		1,600,550
Operating Income		80,410		242,838
Miscellaneous, net		(2,200)		(509)
Total Other (Expense) Income		(10,892)		(24,272)
Income before Income Taxes		69,518		218,566
Adjustment | Accounting Standards Update 2017-07
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of sales		(300)		(838)
Selling, research & development and administrative		(212)		(649)
Total Operating Expenses		(512)		(1,487)
Operating Income		512		1,487
Miscellaneous, net		(512)		(1,487)
Total Other (Expense) Income		$ (512)		$ (1,487)

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018USD ($)$ / shares	Sep. 30, 2017USD ($)$ / sharesshares	Sep. 30, 2018USD ($)segment$ / sharesshares	Sep. 30, 2017USD ($)$ / sharesshares	Dec. 31, 2017USD ($)$ / shares
Number of reportable segments | segment			3
Total Restructuring Initiatives	$ 23,852		$ 48,002
INVESTMENTS IN AFFILIATED COMPANIES
Investment in unconsolidated affiliate			$ 10,000	$ 5,000
RETIREMENT OF COMMON STOCK
Common stock repurchased (retired and held in treasury) (in shares) | shares		546	668	1,400
Common stock repurchased and retired (in shares) | shares			623	512
Common stock, par value (in dollars per share) | $ / shares	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01
INCOME TAXES
Statutory federal income tax rate (as a percent)			21.00%		35.00%
Net tax charge	$ (1,900)		$ (5,400)		$ 24,800
Recognized charge representing provisional estimate of one-time transition tax	900		(2,600)		31,600
Estimate of deferred income tax benefit related to corporate rate change	(2,800)		(2,800)		$ (6,800)
ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS
Provision for Income Taxes	11,920	$ 15,989	52,966	$ 48,043
Beauty + Home
Total Restructuring Initiatives	18,854		38,501
Pharma
Total Restructuring Initiatives	2,008		3,596
Food + Beverage
Total Restructuring Initiatives	2,638		4,307
Corporate & Other
Total Restructuring Initiatives	$ 352		$ 1,598

REVENUE - Revenue by Geographic

REVENUE - Revenue by Geographic Segment (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2018
REVENUE
Net revenue	$ 665,775	$ 2,079,733
Beauty + Home
REVENUE
Net revenue	341,760	1,088,469
Pharma
REVENUE
Net revenue	227,515	698,851
Food + Beverage
REVENUE
Net revenue	96,500	292,413
Europe
REVENUE
Net revenue	381,472	1,232,943
Europe | Beauty + Home
REVENUE
Net revenue	190,267	622,184
Europe | Pharma
REVENUE
Net revenue	161,733	520,574
Europe | Food + Beverage
REVENUE
Net revenue	29,472	90,185
North America
REVENUE
Net revenue	181,349	528,210
North America | Beauty + Home
REVENUE
Net revenue	83,353	252,709
North America | Pharma
REVENUE
Net revenue	50,126	132,496
North America | Food + Beverage
REVENUE
Net revenue	47,870	143,005
Latin America
REVENUE
Net revenue	58,294	182,810
Latin America | Beauty + Home
REVENUE
Net revenue	44,653	140,238
Latin America | Pharma
REVENUE
Net revenue	6,165	19,229
Latin America | Food + Beverage
REVENUE
Net revenue	7,476	23,343
Asia
REVENUE
Net revenue	44,660	135,770
Asia | Beauty + Home
REVENUE
Net revenue	23,487	73,338
Asia | Pharma
REVENUE
Net revenue	9,491	26,552
Asia | Food + Beverage
REVENUE
Net revenue	$ 11,682	$ 35,880

REVENUE - Contract Assets and C

REVENUE - Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Jan. 01, 2018
REVENUE.
Contract asset (current)	$ 15,846	$ 13,984
Increase / (decrease) in contract asset (current)	1,862
Contract liability (current)	413	15
Increase / (decrease) in contract liability (current)	398
Contract liability (long-term)	458	824
Increase / (decrease) in contract liability (long-term)	(366)
Revenue recognized previously included in current contract liabilities	154
Unearned revenue associated with outstanding contracts	871	$ 839
Estimated revenue to be recognized in 2018	102
Estimated revenue to be recognized in 2019	367
Estimated revenue to be recognized after 2019	$ 402

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jan. 01, 2018	Dec. 31, 2017
Inventories, by component
Raw materials	$ 111,985		$ 99,196
Work in process	127,569		107,307
Finished goods	154,710		130,713
Total	$ 394,264	$ 322,579	$ 337,216

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Changes in the carrying amount of goodwill
Goodwill	$ 700,945	$ 445,502
Accumulated impairment losses	(1,615)	(1,615)
Goodwill, Total	699,330	443,887
Acquisition	266,781
Foreign currency exchange effects	(11,338)
Operating segment | Beauty + Home
Changes in the carrying amount of goodwill
Goodwill	224,659	223,947
Goodwill, Total	224,659	223,947
Acquisition	5,565
Foreign currency exchange effects	(4,853)
Operating segment | Pharma
Changes in the carrying amount of goodwill
Goodwill	351,659	203,069
Goodwill, Total	351,659	203,069
Acquisition	154,827
Foreign currency exchange effects	(6,237)
Operating segment | Food + Beverage
Changes in the carrying amount of goodwill
Goodwill	123,012	16,871
Goodwill, Total	123,012	16,871
Acquisition	106,389
Foreign currency exchange effects	(248)
Corporate Non-Segment
Changes in the carrying amount of goodwill
Goodwill	1,615	1,615
Accumulated impairment losses	$ (1,615)	$ (1,615)

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS (Summary of Intangible Assets) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Amortized intangible assets:
Gross Carrying Amount	$ 341,548		$ 341,548		$ 146,103
Accumulated Amortization	(58,438)		(58,438)		(50,643)
Net Value	283,110		283,110		95,460
Aggregate amortization expense	4,005	$ 2,708	9,578	$ 7,643
Future estimated amortization expense
2,018	6,023		6,023
2,019	23,888		23,888
2,020	22,786		22,786
2,021	22,407		22,407
2022 and thereafter	208,006		$ 208,006
Weighted Average
Amortized intangible assets:
Amortization Period			13 years 2 months 12 days
Patents
Amortized intangible assets:
Gross Carrying Amount	7,645		$ 7,645		7,819
Accumulated Amortization	(7,535)		(7,535)		(7,806)
Net Value	110		$ 110		13
Patents | Weighted Average
Amortized intangible assets:
Amortization Period			3 months 18 days
Technology
Amortized intangible assets:
Gross Carrying Amount	93,171		$ 93,171		47,571
Accumulated Amortization	(16,786)		(16,786)		(14,624)
Net Value	76,385		$ 76,385		32,947
Technology | Weighted Average
Amortized intangible assets:
Amortization Period			13 years 6 months
Customer relationships
Amortized intangible assets:
Gross Carrying Amount	199,591		$ 199,591		68,886
Accumulated Amortization	(18,162)		(18,162)		(13,401)
Net Value	181,429		$ 181,429		55,485
Customer relationships | Weighted Average
Amortized intangible assets:
Amortization Period			14 years 7 months 6 days
Trademarks and trade names
Amortized intangible assets:
Gross Carrying Amount	21,333		$ 21,333		6,965
Accumulated Amortization	(5,311)		(5,311)		(4,485)
Net Value	16,022		$ 16,022		2,480
Trademarks and trade names | Weighted Average
Amortized intangible assets:
Amortization Period			7 years
License agreements and other
Amortized intangible assets:
Gross Carrying Amount	19,808		$ 19,808		14,862
Accumulated Amortization	(10,644)		(10,644)		(10,327)
Net Value	$ 9,164		$ 9,164		$ 4,535
License agreements and other | Weighted Average
Amortized intangible assets:
Amortization Period			9 years 3 months 18 days

INCOME TAXES QTR (Details)

INCOME TAXES QTR (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
INCOME TAXES
Statutory federal income tax rate (as a percent)			21.00%		35.00%
Net tax charge	$ (1.9)		$ (5.4)		$ 24.8
Recognized charge representing provisional estimate of one-time transition tax	0.9		(2.6)		31.6
Estimate of deferred income tax benefit related to corporate rate change	$ (2.8)		$ (2.8)		(6.8)
Effective income tax rate (as a percent)	23.40%	23.00%	25.60%	22.00%
Tax benefits from employee share-based compensation	$ (4.5)		$ (9.9)	$ (8.8)
Refunds from settlement of tax claims	(3.5)	$ (4.4)	(3.9)	(3.4)
Additional foreign valuation allowance	1.4
Impact of new tax provisions, including GILTI and BEAT	1.5		6.3
Impact of other discrete and non-discrete tax items	4		4.5
Benefit from repatriation activities to the U.S.				$ 3.6
Income tax uncertainties	3.5		3.5		3.1
Amount of income tax uncertainties that, if recognized, would impact the effective tax rate	3.5		3.5		$ 3.1
Decrease in liability for uncertain tax positions, high end of range	$ 1.5		$ 1.5

DEBT (Details)

DEBT (Details) € in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017EUR (€)	Sep. 30, 2017USD ($)	Sep. 30, 2018EUR (€)	Sep. 30, 2018USD ($)	Dec. 31, 2017USD ($)
Long-Term Obligations
Revolving credit facility maximum borrowing capacity				$ 300,000
Revolving credit facility maturity date			Jul. 1, 2022
Amount outstanding under line of credit				$ 35,000	$ 0
Consolidated Leverage Ratio			2.05	2.05
Consolidated Interest Coverage Ratio			12.36	12.36
Long-term obligations gross including current maturities				$ 1,198,738	1,256,375
Current maturities of long-term obligations				(64,039)	(61,833)
Total long-term obligations				1,134,699	1,194,542
Deferred Finance Costs, Net, Total				2,962	3,396
Deferred debt issuance costs noncurrent				2,962	3,396
Long-term obligations including current maturities				1,195,776	1,252,979
Current maturities of long-term obligations				(64,039)	(61,833)
Long-term obligations, net of unamortized debt issuance costs				1,131,737	1,191,146
Aggregate long-term maturities, excluding capital lease obligations
2,018				62,477
2,019				60,379
2,020				58,316
2,021				133,284
2,022				117,219
Thereafter				$ 758,131
Minimum
Long-Term Obligations
Consolidated Interest Coverage Ratio			3	3
Maximum
Long-Term Obligations
Consolidated Leverage Ratio			3.50	3.50
Revolving credit facility
Long-Term Obligations
Amount outstanding under line of credit | €			€ 89,500
Proceeds from debt | €	€ 150,000
Term of debt	5 years	5 years
Interest rate on notes (as a percent)	1.10%	1.10%
Notes payable to banks
Long-Term Obligations
Proceeds from debt		$ 280,000
Term of debt	5 years	5 years
Long-term obligations gross including current maturities				$ 224,000	280,000
Deferred Finance Costs, Net, Total				578	692
Long-term obligations including current maturities				$ 223,422	279,308
Interest rate on notes (as a percent)	1.36%	1.36%
Floating interest rate prior to conversion to a fixed interest rate	2.56%	2.56%	3.60%	3.60%
Notes payable 0.00% - 18.00%, due in monthly and annual installments through 2025
Long-Term Obligations
Long-term obligations gross including current maturities				$ 17,521	15,349
Long-term obligations including current maturities				$ 17,521	$ 15,349
Notes payable 0.00% - 18.00%, due in monthly and annual installments through 2025 | Minimum
Long-Term Obligations
Interest rate on notes (as a percent)			0.00%	0.00%	0.61%
Notes payable 0.00% - 18.00%, due in monthly and annual installments through 2025 | Maximum
Long-Term Obligations
Interest rate on notes (as a percent)			18.00%	18.00%	18.00%
Senior unsecured notes 3.2%, due in 2022
Long-Term Obligations
Long-term obligations gross including current maturities				$ 75,000	$ 75,000
Deferred Finance Costs, Net, Total				94	113
Long-term obligations including current maturities				$ 74,906	$ 74,887
Interest rate on notes (as a percent)			3.20%	3.20%	3.20%
Senior unsecured notes 3.5%, due in 2023
Long-Term Obligations
Long-term obligations gross including current maturities				$ 125,000	$ 125,000
Deferred Finance Costs, Net, Total				190	217
Long-term obligations including current maturities				$ 124,810	$ 124,783
Interest rate on notes (as a percent)			3.50%	3.50%	3.50%
Senior unsecured notes 0.98%, due in 2023
Long-Term Obligations
Proceeds from private placement | €	€ 100,000
Term of debt	6 years	6 years
Long-term obligations gross including current maturities				$ 116,095	$ 120,095
Deferred Finance Costs, Net, Total				456	526
Long-term obligations including current maturities				115,639	119,569
Interest rate on notes (as a percent)	0.98%	0.98%
Senior unsecured notes 3.4%, due in 2024
Long-Term Obligations
Long-term obligations gross including current maturities				50,000	50,000
Deferred Finance Costs, Net, Total				80	89
Long-term obligations including current maturities				$ 49,920	$ 49,911
Interest rate on notes (as a percent)			3.40%	3.40%	3.40%
Senior unsecured notes 3.5%, due in 2024
Long-Term Obligations
Long-term obligations gross including current maturities				$ 100,000	$ 100,000
Deferred Finance Costs, Net, Total				190	217
Long-term obligations including current maturities				$ 99,810	$ 99,783
Interest rate on notes (as a percent)			3.50%	3.50%	3.50%
Senior unsecured notes 1.17%, due in 2024
Long-Term Obligations
Proceeds from private placement | €	€ 200,000
Term of debt	7 years	7 years
Long-term obligations gross including current maturities				$ 232,190	$ 240,190
Deferred Finance Costs, Net, Total				944	1,066
Long-term obligations including current maturities				231,246	239,124
Interest rate on notes (as a percent)	1.17%	1.17%
Senior unsecured notes 3.6%, due in 2025
Long-Term Obligations
Long-term obligations gross including current maturities				125,000	125,000
Deferred Finance Costs, Net, Total				215	238
Long-term obligations including current maturities				$ 124,785	$ 124,762
Interest rate on notes (as a percent)			3.60%	3.60%	3.60%
Senior unsecured notes 3.6%, due in 2026
Long-Term Obligations
Long-term obligations gross including current maturities				$ 125,000	$ 125,000
Deferred Finance Costs, Net, Total				215	238
Long-term obligations including current maturities				$ 124,785	$ 124,762
Interest rate on notes (as a percent)			3.60%	3.60%	3.60%
Capital lease obligations
Long-Term Obligations
Long-term obligations gross including current maturities				$ 8,932	$ 741
Long-term obligations including current maturities				$ 8,932	$ 741

RETIREMENT AND DEFERRED COMPE_3

RETIREMENT AND DEFERRED COMPENSATION PLANS (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
United States
Change in benefit obligation:
Service cost	$ 2,853	$ 2,426	$ 8,546	$ 7,279
Interest cost	1,713	1,752	5,139	5,257
Change in plan assets:
Employer contribution	20,000
Components of net periodic benefit cost:
Service cost	2,853	2,426	8,546	7,279
Interest cost	1,713	1,752	5,139	5,257
Expected return on plan assets	(2,803)	(2,470)	(8,409)	(7,409)
Amortization of net loss	1,214	801	3,642	2,403
Net periodic benefit cost	2,977	2,509	8,918	7,530
Minimum funding requirements			0
Foreign Plans
Change in benefit obligation:
Service cost	1,457	1,447	4,479	4,166
Interest cost	445	459	1,374	1,321
Change in plan assets:
Employer contribution			1,600
Components of net periodic benefit cost:
Service cost	1,457	1,447	4,479	4,166
Interest cost	445	459	1,374	1,321
Expected return on plan assets	(645)	(627)	(1,982)	(1,781)
Amortization of net loss	422	493	1,301	1,400
Amortization of prior service cost	122	104	376	296
Net periodic benefit cost	1,801	$ 1,876	5,548	$ 5,402
Expected contribution in current fiscal year	$ 3,100		$ 3,100

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Accumulated other comprehensive income activity
Balance at the beginning of the period	$ 1,311,738
Balance at the end of the period	1,391,744
Foreign Currency
Accumulated other comprehensive income activity
Balance at the beginning of the period	(185,503)	$ (259,888)
Other comprehensive income (loss) before reclassifications	(53,141)	69,493
Net current-period other comprehensive income (loss)	(53,141)	69,493
Balance at the end of the period	(238,644)	(190,395)
Defined Benefit Pension Plans
Accumulated other comprehensive income activity
Balance at the beginning of the period	(64,595)	(59,775)
Amounts reclassified from accumulated other comprehensive income	4,032	2,699
Net current-period other comprehensive income (loss)	4,032	2,699
Balance at the end of the period	(60,563)	(57,076)
Derivatives
Accumulated other comprehensive income activity
Balance at the beginning of the period	(3,204)	(46)
Other comprehensive income (loss) before reclassifications	12,507	(9,237)
Amounts reclassified from accumulated other comprehensive income	(11,444)	5,667
Net current-period other comprehensive income (loss)	1,063	(3,570)
Balance at the end of the period	(2,141)	(3,616)
Accumulated Other Comprehensive Income/(Loss)
Accumulated other comprehensive income activity
Balance at the beginning of the period	(253,302)	(319,709)
Other comprehensive income (loss) before reclassifications	(40,634)	60,256
Amounts reclassified from accumulated other comprehensive income	(7,412)	8,366
Net current-period other comprehensive income (loss)	(48,046)	68,622
Balance at the end of the period	$ (301,348)	$ (251,087)

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE INCOME (Reclassifications From Accumulated Other Comprehensive Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Amount Reclassified from Accumulated Other Comprehensive Income
Miscellaneous, net	$ (2,928)	$ (2,712)	$ (4,372)	$ (1,996)
Interest expense	8,735	9,733	24,754	25,707
Total before tax	(50,942)	(69,518)	(207,057)	(218,566)
Tax benefit	11,920	15,989	52,966	48,043
Total reclassifications for the period	(38,996)	(53,523)	(154,071)	(170,517)
Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Total reclassifications for the period	(1,543)	6,577	(7,412)	8,366
Defined Benefit Pension Plans | Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Amortization of net loss	1,636	1,294	4,943	3,803
Amortization of prior service cost	122	104	376	296
Total before tax	1,758	1,398	5,319	4,099
Tax benefit	(425)	(474)	(1,287)	(1,400)
Total reclassifications for the period	1,333	924	4,032	2,699
Derivatives | Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Total before tax	(3,464)	6,814	(13,782)	6,835
Tax benefit	588	(1,161)	2,338	(1,168)
Total reclassifications for the period	(2,876)	5,653	(11,444)	5,667
Derivatives | Treasury locks | Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Interest expense	4	11	26	32
Derivatives | Cross Currency Swap Contract: Interest Component | Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Interest expense	(1,337)	(678)	(3,824)	(678)
Derivatives | Cross Currency Swap Contract: Foreign Exchange Component | Amount Reclassified from Accumulated Other Comprehensive Income
Amount Reclassified from Accumulated Other Comprehensive Income
Miscellaneous, net	$ (2,131)	$ 7,481	$ (9,984)	$ 7,481

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Cash Flow Hedge) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Jul. 20, 2017
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Net after-tax loss included in accumulated other comprehensive earnings	$ 1,166	$ 3,591	$ (1,046)	$ 3,591
Derivatives in Cash Flow Hedging Relationships
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	2,063	(11,129)	15,068	$ (11,129)
Cross Currency Swap Contract | Derivatives in Cash Flow Hedging Relationships
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount hedged					$ 280,000
Net after-tax loss included in accumulated other comprehensive earnings			2,100
Fair value of derivative liability	4,700		4,700
Cross Currency Swap Contract: Interest Component | Derivatives in Cash Flow Hedging Relationships
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount expected to be recognized in earnings in next twelve months related to cross currency swap contract	$ 4,800		$ 4,800
Notes payable to banks
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Proceeds from debt		$ 280,000

DERIVATIVE INSTRUMENTS AND HE_4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Fair Value of Derivative Instruments in the Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Fair Value of Derivative Instruments
Derivative Assets	$ 262		$ 262		$ 663
Derivative Liabilities	5,593		5,593		17,913
Cash delivered on foreign currency forward contract				$ 66,155
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	(1,011)	$ (15,534)	102	(64,651)
Foreign Exchange Contracts
Fair Value of Derivative Instruments
Aggregate amount of forward exchange contracts outstanding	103,900		103,900
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	(1,011)	$ (15,534)	102	$ (64,651)
Derivative Contracts Not Designated as Hedging Instruments
Fair Value of Derivative Instruments
Derivative Assets	262		262		663
Derivative Liabilities	881		881		1,604
Derivative Contracts Not Designated as Hedging Instruments | Foreign Exchange Contracts | Prepayments and other
Fair Value of Derivative Instruments
Derivative Assets	262		262		663
Derivative Contracts Not Designated as Hedging Instruments | Foreign Exchange Contracts | Accounts payable and accrued liabilities
Fair Value of Derivative Instruments
Derivative Liabilities	881		881		1,604
Derivative Contracts Designated as Hedging Instruments
Fair Value of Derivative Instruments
Derivative Liabilities	4,712		4,712		16,309
Derivative Contracts Designated as Hedging Instruments | Cross Currency Swap Contract | Accounts payable and accrued liabilities
Fair Value of Derivative Instruments
Derivative Liabilities	$ 4,712		$ 4,712		$ 16,309

DERIVATIVE INSTRUMENTS AND HE_5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effect of Derivative Instruments on the Consolidated Statements of Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Derivative instruments, gain or (loss)
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	$ (1,011)	$ (15,534)	$ 102	$ (64,651)
Derivatives in Cash Flow Hedging Relationships
Derivative instruments, gain or (loss)
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	2,063	(11,129)	15,068	(11,129)
Amount of Gain (Loss) Reclassified from AOCI on Derivative	3,468	(6,803)	13,808	(6,803)
Foreign Exchange Contracts
Derivative instruments, gain or (loss)
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	(1,011)	(15,534)	102	(64,651)
Cross Currency Swap Contract: Interest Component | Interest expense | Derivatives in Cash Flow Hedging Relationships
Derivative instruments, gain or (loss)
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	(68)	(3,648)	5,084	(3,648)
Amount of Gain (Loss) Reclassified from AOCI on Derivative	1,337	678	3,824	678
Cross Currency Swap Contract: Foreign Exchange Component | Other Income (Expense): Miscellaneous, net | Derivatives in Cash Flow Hedging Relationships
Derivative instruments, gain or (loss)
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	2,131	(7,481)	9,984	(7,481)
Amount of Gain (Loss) Reclassified from AOCI on Derivative	$ 2,131	$ (7,481)	$ 9,984	$ (7,481)

DERIVATIVE INSTRUMENTS AND HE_6

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Assets and Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Derivative Assets
Gross Amount	$ 262	$ 663
Net Amounts Presented in the Statement of Financial Position	262	663
Net Amount	262	663
Derivative Liabilities
Gross Amount	5,593	17,913
Net Amounts Presented in the Statement of Financial Position	5,593	17,913
Net Amount	$ 5,593	$ 17,913

FAIR VALUE (Details)

FAIR VALUE (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Liabilities
Fair value of long-term obligations	$ 1,100,000	$ 1,100,000
Assets and liabilities measured at fair value on recurring basis
Assets
Foreign exchange contracts, assets	262	663
Total assets at fair value	262	663
Liabilities
Foreign exchange contracts, liabilities	881	1,604
Cross currency swap contract, liability	4,712	16,309
Total liabilities at fair value	5,593	17,913
Assets and liabilities measured at fair value on recurring basis | Level 2
Assets
Foreign exchange contracts, assets	262	663
Total assets at fair value	262	663
Liabilities
Foreign exchange contracts, liabilities	881	1,604
Cross currency swap contract, liability	4,712	16,309
Total liabilities at fair value	$ 5,593	$ 17,913

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	3 Months Ended
	Sep. 30, 2018	Mar. 31, 2017	Jun. 30, 2018	Dec. 31, 2017
Brazil
Commitments and contingencies
Environmental Remediation Expense	$ 0	$ 1,500,000
Brazil | Minimum
Commitments and contingencies
Environmental Loss Contingencies Estimate	1,500,000
Brazil | Maximum
Commitments and contingencies
Environmental Loss Contingencies Estimate	3,000,000
United States
Commitments and contingencies
Accrual for Environmental Loss Contingencies			$ 750,000
Payments to settle environmental loss contingency	239,000
Indemnification agreements
Commitments and contingencies
Liabilities recorded under indemnification agreements	$ 0			$ 0

STOCK REPURCHASE PROGRAM (Detai

STOCK REPURCHASE PROGRAM (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Oct. 20, 2016
STOCK REPURCHASE PROGRAM
Share repurchases authorized amount				$ 350,000
Aggregate amount of share repurchases (in dollars)	$ 45,542	$ 3,905	$ 72,270
Common stock repurchased (retired and held in treasury) (in shares)	546	668	1,400
Common stock repurchased (retired and held in treasury)	$ 45,500	$ 61,700	$ 113,300
Common stock repurchased and retired (in shares)		623	512
Common stock repurchased and retired		$ 57,787	$ 40,994
Remaining authorized repurchase amount		$ 80,200

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
STOCK-BASED COMPENSATION
Proceeds from stock option exercises	$ 78,896	$ 66,686
Stock options
STOCK-BASED COMPENSATION
Award vesting period	3 years
Expiration period	10 years
Compensation expense	$ 8,900	12,600
Compensation expense, net of tax	6,900	8,600
Income tax benefit related to compensation expense	2,000	4,000
Fair value of shares vested	16,500	16,900
Proceeds from stock option exercises	78,900
Actual tax benefit realized for the tax deduction from option exercises	15,500
Unrecognized compensation cost expected to be recognized in future periods	$ 10,700
Weighted-average period over which compensation cost is expected to be recognized	1 year 8 months 12 days
Stock options | Selling, research & development and administrative expenses
STOCK-BASED COMPENSATION
Compensation expense	$ 7,100	11,000
Restricted stock units
STOCK-BASED COMPENSATION
Compensation expense	5,900	2,400
Actual tax benefit realized for the tax deduction from option exercises	718
Unrecognized compensation cost expected to be recognized in future periods	$ 23,200
Weighted-average period over which compensation cost is expected to be recognized	2 years 4 months 24 days
Weighted-Average Grant-Date Fair Value
Fair value of units vested	$ 2,600	4,700
Intrinsic value of units vested	$ 3,100	$ 5,200
Restricted stock units (time-based)
STOCK-BASED COMPENSATION
Award vesting period	3 years
Restricted stock unit activity
Balance at the beginning of the period (in shares)	124,067
Granted (in shares)	187,502
Vested (in shares)	(33,882)
Forfeited (in shares)	(31,672)
Balance at the end of the period (in shares)	246,015
Weighted-Average Grant-Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$ 74.65
Granted (in dollars per share)	96.26
Vested (in dollars per share)	75.57
Forfeited (in dollars per share)	78.62
Nonvested at the end of the period (in dollars per share)	$ 90.48
Restricted stock units (performance-based)
STOCK-BASED COMPENSATION
Award vesting period	3 years
Assumptions used to estimate fair value of stock options granted
Dividend Yield (as a percent)	1.43%
Expected Stock Price Volatility (as a percent)	12.30%
Risk-free Interest Rate (as a percent)	2.42%
Assumptions used to estimate fair value of restricted stock units granted
Fair value per stock award (in dollars per share)	$ 128.70
Grant date stock price (in dollars per share)	$ 89.42
Expected Stock Price Volatility (as a percent)	12.30%
Expected average volatility of peer companies (as a percent)	27.50%
Correlation assumption (as a percent)	20.20%
Risk-free Interest Rate (as a percent)	2.42%
Dividend Yield (as a percent)	1.43%
Restricted stock unit activity
Granted (in shares)	80,843
Forfeited (in shares)	(9,762)
Balance at the end of the period (in shares)	71,081
Weighted-Average Grant-Date Fair Value
Granted (in dollars per share)	$ 111.55
Forfeited (in dollars per share)	111.55
Nonvested at the end of the period (in dollars per share)	111.55
Stock Awards Plans | Stock options
STOCK-BASED COMPENSATION
Weighted-average fair value of stock options granted (in dollars per share)	$ 14.82	$ 11.86
Assumptions used to estimate fair value of stock options granted
Dividend Yield (as a percent)	1.50%	1.70%
Expected Stock Price Volatility (as a percent)	14.20%	15.80%
Risk-free Interest Rate (as a percent)	2.80%	2.20%
Expected Life of Option (years)	6 years 7 months 6 days	6 years 8 months 12 days
Stock options activity
Outstanding at the beginning of the period (in shares)	8,059,319
Granted (in shares)	603,901
Exercised (in shares)	(1,439,333)
Forfeited or expired (in shares)	(243,110)
Outstanding at the end of the period (in shares)	6,980,777
Exercisable at the end of the period (in shares)	5,114,822
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 61.67
Granted (in dollars per share)	88.39
Exercised (in dollars per share)	52.69
Forfeited or expired (in dollars per share)	74.32
Outstanding at the end of the period (in dollars per share)	65.39
Exercisable at the end of the period (in dollars per share)	$ 60.65
Weighted-Average Remaining Contractual Term (Years):
Outstanding at the end of the period	6 years
Exercisable at the end of the period	5 years 2 months 12 days
Aggregate Intrinsic Value:
Outstanding at the end of the period	$ 295,630
Exercisable at the end of the period	240,839
Intrinsic Value of Options Exercised	$ 62,895	$ 44,734
Assumptions used to estimate fair value of restricted stock units granted
Expected Stock Price Volatility (as a percent)	14.20%	15.80%
Risk-free Interest Rate (as a percent)	2.80%	2.20%
Dividend Yield (as a percent)	1.50%	1.70%
Director Stock Option Plans | Stock options
Stock options activity
Outstanding at the beginning of the period (in shares)	214,967
Exercised (in shares)	(57,767)
Outstanding at the end of the period (in shares)	157,200
Exercisable at the end of the period (in shares)	157,200
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 57.44
Exercised (in dollars per share)	55.71
Outstanding at the end of the period (in dollars per share)	58.08
Exercisable at the end of the period (in dollars per share)	$ 58.08
Weighted-Average Remaining Contractual Term (Years):
Outstanding at the end of the period	4 years 3 months 18 days
Exercisable at the end of the period	4 years 3 months 18 days
Aggregate Intrinsic Value:
Outstanding at the end of the period	$ 7,807
Exercisable at the end of the period	7,807
Intrinsic Value of Options Exercised	$ 2,187	$ 1,995
Director Stock Option Plans | Restricted stock units
STOCK-BASED COMPENSATION
Award vesting period	1 year
Director Stock Option Plans | Restricted stock units (time-based)
Restricted stock unit activity
Granted (in shares)	14,257
Vested (in shares)	(14,793)
New long-term incentive program
STOCK-BASED COMPENSATION
Compensation expense	$ 1,800	$ 1,500
Expected total expense related to program over the performance period	$ 3,700

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Earning per share
Authorized common stock (in shares)	199,000		199,000		199,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Income (Numerator)
Income available to common stockholders, basic (in dollars)	$ 38,996	$ 53,523	$ 154,071	$ 170,517
Income available to common stockholders, diluted (in dollars)	$ 38,996	$ 53,523	$ 154,071	$ 170,517
Shares (Denominator)
Basic (in shares)	62,378	62,592	62,304	62,527
Total average equivalent shares	65,129	64,821	64,822	64,626
Per Share Amount
Net income per share, basic (in dollars per share)	$ 0.63	$ 0.86	$ 2.47	$ 2.73
Net income per share, diluted (in dollars per share)	$ 0.60	$ 0.83	$ 2.38	$ 2.64
Stock options
Shares (Denominator)
Effect of dilutive stock based compensation (in shares)	2,659	2,171	2,440	2,046
Restricted stock units
Shares (Denominator)
Effect of dilutive stock based compensation (in shares)	92	58	78	53

SEGMENT INFORMATION (Summary of

SEGMENT INFORMATION (Summary of Reportable Segments) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2018USD ($)segment	Sep. 30, 2017USD ($)	Dec. 31, 2017USD ($)
Financial information regarding the Company's reportable segments
Number of reportable segments | segment			3
Net sales	$ 665,775	$ 624,326	$ 2,079,733	$ 1,843,388
Acquisition related costs	(10,369)		(12,932)
Depreciation and amortization	41,857	40,087	123,133	114,660
Interest expense	(8,735)	(9,733)	(24,754)	(25,707)
Interest income	1,537	1,113	6,306	2,086
Income before Income Taxes	50,942	69,518	207,057	218,566
Capital Expenditures			145,321	120,803
Total Assets	3,406,996		3,406,996		$ 3,137,823
Restructuring Initiatives by Segment
Total Restructuring Initiatives	23,852		48,002
Employee severance
Restructuring Initiatives by Segment
Total Restructuring Initiatives			2,035
Beauty + Home
Financial information regarding the Company's reportable segments
Net sales	341,760	333,748	1,088,469	978,313
Adjusted EBITDA	42,174	42,627	141,155	129,265
Restructuring Initiatives by Segment
Total Restructuring Initiatives	18,854		38,501
Pharma
Financial information regarding the Company's reportable segments
Net sales	227,515	199,547	698,851	598,161
Adjusted EBITDA	84,516	66,260	250,709	204,750
Restructuring Initiatives by Segment
Total Restructuring Initiatives	2,008		3,596
Food + Beverage
Financial information regarding the Company's reportable segments
Net sales	96,500	91,031	292,413	266,914
Adjusted EBITDA	15,482	18,116	46,284	49,756
Restructuring Initiatives by Segment
Total Restructuring Initiatives	2,638		4,307
Corporate & Other
Financial information regarding the Company's reportable segments
Adjusted EBITDA	(7,954)	(8,778)	(28,576)	(26,924)
Restructuring Initiatives by Segment
Total Restructuring Initiatives	352		1,598
Operating segment
Financial information regarding the Company's reportable segments
Net sales	671,028	629,471	2,097,131	1,859,803
Operating segment | Beauty + Home
Financial information regarding the Company's reportable segments
Net sales	346,040	338,068	1,103,664	992,476
Operating segment | Pharma
Financial information regarding the Company's reportable segments
Net sales	227,691	199,551	699,105	598,168
Operating segment | Food + Beverage
Financial information regarding the Company's reportable segments
Net sales	97,297	91,852	294,362	269,159
Intersegment
Financial information regarding the Company's reportable segments
Net sales	5,253	5,145	17,398	16,415
Intersegment | Beauty + Home
Financial information regarding the Company's reportable segments
Net sales	4,280	4,320	15,195	14,163
Intersegment | Pharma
Financial information regarding the Company's reportable segments
Net sales	176	4	254	7
Intersegment | Food + Beverage
Financial information regarding the Company's reportable segments
Net sales	$ 797	$ 821	$ 1,949	$ 2,245

INSURANCE SETTLEMENT RECEIVAB_2

INSURANCE SETTLEMENT RECEIVABLE (Details) - France - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
INSURANCE SETTLEMENT RECEIVABLE
Costs incurred related to fire	$ 3.2	$ 4.5	$ 14.1	$ 14.4
Advances on insurance proceeds received	24.2		24.2
Insurance receivable	0		0
Gain contingencies recognized	0		0
Expenses related to fire	1.5	$ 1.4	$ 4.4	$ 4.1
Beauty + Home
INSURANCE SETTLEMENT RECEIVABLE
Expenses related to fire	0.5
Pharma
INSURANCE SETTLEMENT RECEIVABLE
Expenses related to fire	$ 1

ACQUISITIONS (Details)

ACQUISITIONS (Details) $ in Thousands	Aug. 27, 2018USD ($)	May 01, 2018USD ($)	Feb. 28, 2017USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	May 31, 2018USD ($)	Dec. 31, 2017USD ($)
Acquisitions
Investment in unconsolidated affiliate					$ 10,000	$ 5,000
Acquisition of business, net of cash received					527,916
Acquisition related costs				$ (10,369)	(12,932)
Restricted cash included in prepaid and other				5,000	5,000
Assets
Goodwill				699,330	699,330			$ 443,887
Preferred equity stocks
Acquisitions
Cost method investments							$ 10,000
Reboul
Acquisitions
Percentage of interest acquired		100.00%
Cost of acquired entity		$ 3,600
Fair value of contingent consideration arrangement		0
Assets
Cash and equivalents		$ 112
Kali Care
Acquisitions
Percentage of interest acquired			20.00%
Investment in unconsolidated affiliate			$ 5,000
CSP Technologies Member
Acquisitions
Cost of acquired entity	$ 553,500
Sales of acquiree during the reporting period				13,200
Pretax income of acquiree during the reporting period				(1,900)
Fair value adjustment for inventory sold during the quarter				3,300
Acquisition related costs				7,100	9,000
Restricted cash included in prepaid and other				5,000	$ 5,000
Assets
Cash and equivalents	24,053
Accounts receivable	21,250
Inventories	45,500
Prepaid and other	2,925
Property, plant and equipment	101,579
Goodwill	261,216
Intangible assets	198,200
Other miscellaneous assets	980
Liabilities
Current maturities of long-term obligations	129
Accounts payable and accrued liabilities	30,871
Long-term obligations	6,037
Deferred income taxes	47,504
Retirement and deferred compensation plans	212
Deferred and other non-current liabilities	17,492
Net assets acquired	$ 553,458
France | CSP Technologies Member
Acquisitions
Number of manufacturing plants acquired	1
United States | CSP Technologies Member
Acquisitions
Number of manufacturing plants acquired	2
Pharma | CSP Technologies Member
Acquisitions
Sales of acquiree during the reporting period				9,400
Pretax income of acquiree during the reporting period				(1,800)
Assets
Goodwill	$ 154,800
Food + Beverage | CSP Technologies Member
Acquisitions
Sales of acquiree during the reporting period				3,800
Pretax income of acquiree during the reporting period				$ (100)
Assets
Goodwill	$ 106,400

ACQUISITIONS (Acquired Intangib

ACQUISITIONS (Acquired Intangibles) (Details) - CSP Technologies Member $ in Thousands	Aug. 27, 2018USD ($)
Acquired finite-lived intangible assets
Estimated Fair Value of Asset	$ 198,200
Technology
Acquired finite-lived intangible assets
Weighted average useful life	12 years
Estimated Fair Value of Asset	$ 46,700
Customer relationships
Acquired finite-lived intangible assets
Weighted average useful life	16 years
Estimated Fair Value of Asset	$ 132,300
Trademarks and trade names
Acquired finite-lived intangible assets
Weighted average useful life	9 years
Estimated Fair Value of Asset	$ 14,600
License agreements and other
Acquired finite-lived intangible assets
Weighted average useful life	9 years
Estimated Fair Value of Asset	$ 4,600

ACQUISITIONS (Pro Forma) (Detai

ACQUISITIONS (Pro Forma) (Details) - CSP Technologies Member - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Unaudited pro forma financial information
Net Sales	$ 687,201	$ 659,741	$ 2,172,737	$ 1,943,297
Net Income Attributable to AptarGroup, Inc.	$ 48,034	$ 57,829	$ 158,527	$ 168,028
Net Income per common share - basic	$ 0.77	$ 0.92	$ 2.54	$ 2.69
Net Income per common share - diluted	$ 0.74	$ 0.89	$ 2.45	$ 2.60
Acquisition Related Costs
Acquisitions
Transaction costs excluded from supplemental pro forma earnings (after tax)	$ 14,200		$ 16,600
Transaction costs excluded from supplemental pro forma earnings (before tax)	18,500		21,900
Fair Value Adjustment
Acquisitions
Nonrecurring expense related to the fair value adjustment to acquisition-date inventory excluded from supplemental pro forma earnings (after tax)	2,600		2,600
Nonrecurring expense related to the fair value adjustment to acquisition-date inventory excluded from supplemental pro form earnings (before tax)	$ 3,300		$ 3,300

RESTRUCTURING INITIATIVE (Detai

RESTRUCTURING INITIATIVE (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2018USD ($)	Sep. 30, 2018USD ($)
Restructuring reserve
Restructuring reserve, balance at the beginning of the period		$ 2,258
Expense recognized related to the plan	$ 23,852	48,002
Cash paid		(37,447)
FX impact		585
Restructuring reserve, balance at the end of the period	13,398	13,398
Employee severance
Restructuring reserve
Restructuring reserve, balance at the beginning of the period		2,258
Expense recognized related to the plan		2,035
Cash paid		(2,414)
FX impact		(52)
Restructuring reserve, balance at the end of the period	1,827	1,827
Professional fees and other costs
Restructuring reserve
Expense recognized related to the plan		45,967
Cash paid		(35,033)
FX impact		637
Restructuring reserve, balance at the end of the period	11,571	11,571
Business Transformation
Restructuring initiatives
Expected future implementation costs	90,000	$ 90,000
Expected term of additional implementation costs		P3Y
Expected future capital investments related to transformation plan	54,000	$ 54,000
Beauty + Home
Restructuring reserve
Expense recognized related to the plan	18,854	38,501
Pharma
Restructuring reserve
Expense recognized related to the plan	2,008	3,596
Food + Beverage
Restructuring reserve
Expense recognized related to the plan	2,638	4,307
Corporate & Other
Restructuring reserve
Expense recognized related to the plan	$ 352	$ 1,598